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ABSTRACT 
Dietary Milk Fat globule membrane reduces the incidence of aberrant crypt foci in 
fischer-344 rats and provides protections against gastrointestinal stress in mice treated  
with Lipopolysaccharide  
by 
Dallin Snow, Master of Science 
Utah State University, 2010 
Major Professor: Dr. Korry J. Hintze 
Department: Nutrition, Dietetics and Food Sciences 
	   Milk fat globule membrane surrounds the fat droplets of milk.  It is a biopolymer 
containing primarily membrane glycoproteins and polar lipids which contribute to its 
properties as a possible neutraceutical.  The aims of the studies were to determine if 
dietary milk fat globule membrane: (1) confers protection against colon carcinogenesis; 
and (2) promotes gut mucosal integrity while decreasing inflammation compared to diets 
containing corn oil or anhydrous milk fat.   
Aim 1.  Three dietary treatments differing only in the fat source were formulated: 
(1) AIN-76A, corn oil; (2) AIN-76A, anhydrous milk fat; and (3) AIN-76A, 50% milk fat 
globule membrane, 50% anhydrous milk fat.  Each diet was formulated to contain 50 
g/kg diet of fat and to be identical in macro and micro nutrient content.  To assess 
protection against colon carcinogenesis, male, weanling Fischer-344 rats were randomly 
assigned to one of the three dietary treatments.  Animals were injected with 1,2- 
iv	  
dimethylhydrazine once per week at weeks 3 and 4.  After 13 weeks animals were 
sacrificed, colons were removed, and aberrant crypt foci were counted by microscopy.   
Rats fed the milk fat globule membrane diet (n = 16) had significantly fewer 
aberrant crypt foci (20.9 ± 5.7) compared to rats fed corn oil (n = 17) or anhydrous milk 
fat (n = 16) diets (31.3 ± 9.5 and 29.8 ± 11.4 respectively; P < 0.05).   
Aim 2.  Male BALB/c mice were randomly assigned to one of two diets: AIN-
76A, corn oil or AIN-76A, 50% milk fat globule membrane, 50% anhydrous milk fat.  
After 5 weeks mice were injected with saline vehicle control or lipopolysaccharide and 
gavaged with dextran-FITC.  To assess gut mucosal integrity and inflammation, serum 
samples were assayed for dextran-FITC 24 and 48 hours after gavage, and a panel of 16 
cytokine concentrations was analyzed. 
Serum concentrations of IL-6, IL-10, IL-17, MCP-1, IFNγ, and TNFα decreased 
and gut permeability decreased 45% in lipopolysaccharide challenged mice fed milk fat 
globule membrane diet compared to control diet at 24 hours (P < 0.05). 
Overall, the results of these aims suggest that diets containing milk fat globule 
membrane are protective against colon carcinogenesis, inhibit the inflammatory response, 
and protect against gastrointestinal stress. 
(99 pages) 
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CHAPTER I 
INTRODUCTION 
 Milk fat globule membrane (MFGM) is a biopolymer composed of a protein-lipid 
complex surrounding fat droplets in milk.  It is formed as the fat droplets originating in 
the endoplasmic reticulum travel to the apical surface of epithelial cells and pass through 
the apical membrane into the alveolar lumen.  This process encapsulates the fat droplets 
in a plasma membrane and the MFGM is formed (1).  Characterizations of MFGM have 
shown it to have a complex carbohydrate, lipid, and protein profile (2-4), which has led to 
many studies facilitating its recovery and isolation.   
The discovery that many of the proteins in MFGM have positive biochemical 
effects has led to the suggestion that MFGM contains nutraceutical properties (5-8).  
MFGM also contains sphingolipids which are present in intestinal epithelial cells and are 
thought to have an influence on colon carcinogenesis and inflammation (9-10). 
Studies have demonstrated that purified forms of sphingomyelin and 
glycosphingolipids (both different types of sphingolipids) isolated from milk inhibit 
chemically induced colon cancer in a mouse model (11-12).  Other studies have shown 
that sphingolipids and other milk fat fractions containing phospholipids and gangliosides 
are linked to the inhibition of a pro-inflammatory response (13-15).  One recent study 
concluded that dietary gangliosides take part in the protection of the gut barrier during 
acute gut inflammation by preventing the breakdown of gut occludin tight junction 
protein (16).  
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While MFGM contains sphingomyelin (as well as other polar lipids) and proteins 
that have been demonstrated to have positive effects in the gut, they are not in a purified 
form.  Rather, MFGM is a combination of proteins and polar lipids thought to be health-
promoting.  To date, no other studies have examined the effects of MFGM as a whole 
dietary component on colon cancer and gut barrier integrity making these studies 
extremely novel. 
The first aim is to determine if dietary MFGM confers any protection against 
colon carcinogenesis compared to diets containing corn oil or anhydrous milk fat and 
whether or not MFGM’s protective properties occur by gene regulation.  The second aim 
is to determine if dietary MFGM promotes gut mucosal integrity while decreasing  
inflammation. 
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CHAPTER II 
DIETARY MILK FAT GLOBULE MEMBRANE REDUCES THE INCIDENCE OF 
ABERRANT CRYPT FOCI IN FISCHER-344 RATS1 
Introduction 
Colon cancer is the third most commonly diagnosed cancer in the United States 
and the second most common cause of cancer-related deaths (1).  Diet is a well 
recognized contributing factor to the etiology of cancer and may be associated with 35–
70% of the incidence of colon cancer (2).  Although various carcinogens are present in 
foods, their effects may be minor when compared with dietary components that inhibit the 
cancer process (2).  As a consequence, many dietary treatments have been tested 
specifically for their ability to inhibit colon cancer. 
 Previous studies have demonstrated that purified sphingolipids, such as 
sphingomyelin, are protective against colon cancer in animal models (3, 4).  
Sphingolipids are composed of a ceramide core, which in turn, is composed of a 
sphingosine backbone with a fatty acid covalently bonded via an amide linkage.  Several 
different head groups may be covalently attached to the ceramide, each resulting in a  
different class of sphingolipid.  Examples include sphingomyelin, with a phosphocholine 
headgroup, glycosphingolipids with one or more monosaccharides in the headgroup and 
gangliosides, which have at least three sugars in head group including at least one sialic 
    
 1Reproduced with permission from Snow, D. R.; Jimenez-Flores, R.; Ward, R. E.; 
Cambell, J.; Young, M. J.; Nemere, I.; Hintze, K. J. Dietary milk fat globule membrane 
reduces the incidence of aberrant crypt foci in fischer-344 rats. J. Agric. Food Chem. 
2010, 58 (4), 2157-2163. Copyright 2010 American Chemical Society. 
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acid.  The anticancer activity of sphingolipids is primarily associated with their  
metabolites, ceramide and sphingosine (5).  Ceramide is an important second messenger 
implicated in various physiological functions, like apoptosis, and has recently been 
associated with targeting mitochondrial activity in colon cancer cells (6, 7).  Sphingolipid 
digestion is slow and occurs along the entire length of both the small intestine and the 
colon which results in high levels of ceramide and sphingosine in the lumen producing 
the potentially beneficial effects (8).  Dietary sphingomyelin and glycosphingolipids 
isolated from milk have been shown to inhibit chemically induced colon cancer in a 
mouse model (9, 10), and administration either before or after tumor initiation reduced 
tumor formation (11). 
 One significant source of dietary sphingolipids is the milk fat globule membrane 
(MFGM), a protein-lipid complex that is derived from the apical surface of mammary 
epithelial cells and surrounds the fat globules in milk.  During the synthesis of milk, fat 
droplets originate in the endoplasmic reticulum and transit directly to the apical surface 
of the cell.  As they transit out of the epithelial cells and into the alveolar lumen they pass 
through the apical membrane and are encapsulated in the plasma membrane complete 
with the exterior glycocalyx (12).  A result of this process is that milk fat is present as 
discrete globules, which range from 0.1 to about 15 µm in diameter (13).  The globules 
are composed of a nonpolar lipid core (mainly triglycerides) surrounded by the MFGM, 
which is composed of phospholipids and membrane glycoproteins (see Table 1 for major 
components of MFGM).  Triglycerides are the dominant lipid class, and account for 
approximately 98% of milk fat, while the balance is composed of phospholipids (0.8%), 
 
7	  
 
diglycerides (0.3%), monoglycerides (0.03%), cholesterol (0.3%), and free fatty acids 
(0.1%) (14). 
While there is some MFGM in all dairy fats, it is especially enriched in churn 
buttermilk, a co-product of butter manufacture.  When cream is churned to make butter, 
the MFGM is released from the surface of milk fat globules, and it is recovered in the 
aqueous phase.  Because of its unique lipid profile, relative sphingolipid enrichment and 
widespread availability, MFGM is a good candidate for a colon chemopreventive, 
bioactive ingredient.  MFGM has an interesting profile of carbohydrates, lipids and 
proteins, as has recently been demonstrated in several proteomic and lipidomic 
characterizations (15-17), and as such it is the most diverse fraction of milk.  The unique 
compositional feature has led to the suggestion that MFGM may have interesting 
nutraceutical properties (18), and several research groups have conducted studies to 
facilitate its recovery from buttermilk (19-30).  
 Although very few studies have been conducted to determine any nutritional 
benefits of MFGM, some indicate positive effects.  A recent study concluded digestion 
products of MFGM may have antimicrobial activity (31).  Because of its unique 
Table 1: Major Components of MFGM (Adapted from (12)) 
Lipids % Polar lipids % Proteins 
Triacylglycerols 62 Sphingomyelin 22 Mucin 1 
Diacylglycerols 9 Phosphatidylcholine 36 Xanthine oxidoreductase 
Monoacylglycerols Trace Phosphatidylethanolamine 27 PAS III 
Sterols 0.2-2 Phosphatidylinositol 11 CD 36 
Sterol esters 0.1-0.3 Phosphatidylserine 4 Butyrophilin 
Free Fatty acids 0.6-6 Lysophosphatidylcholine 2 PAS 6/7 
Hydrocarbons 1.2   Adipophilin 
Phospholipids 26-31   Fatty acid binding 
protein 
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biochemical nature, sphingolipid enrichment and resulting putative chemoprotective 
properties, we investigated whether diets containing MFGM are protective against colon  
cancer in Fischer-344 rats using the aberrant crypt foci (ACF) model. 
Materials and Methods 
Isolation of Milk Fat Globule Membrane 
Sweet cream was obtained from Cal Poly Dairy Farm milk by centrifugation after 
pasteurization.  It was churned after a waiting period of 16 h at 4 °C using a continuous 
pilot scale butter churn (Egli AG, Bütschwil, Switzerland).  Buttermilk was recovered 
and butter fines were removed by filtration through cheese cloth. 
A pilot plant scale system (R-12 model, GEA-Niro Filtration, Hudson, WI,) using 
two spiral polymeric membranes fitted in parallel on the module (10 kDa molecular 
weight cutoff, 11.33 m2 total surface area) was used for buttermilk concentration.  The 
process was carried out at 25 °C, the transmembrane pressure was 6 bar and the feed 
pump was operated at 35 Hz.  The ultrafiltration was conducted until a 10-fold 
volumetric concentration factor was reached.  Diafiltration was completed by adding tap 
water continuously at 25 °C to the feed tank to replace the removed permeate until 
reaching a 5-fold diafiltration factor.  In each step of the filtration, samples of retentates 
were collected for composition analysis and the permeate flux was measured.  The final 
retentates were spray-dried (Niro Filterlab Spray-drier, Hudson, WI,) to obtain whey 
buttermilk powders. 
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Diet formulation  
Diets were formulated to differ only in fat composition.  This was achieved by 
analyzing the composition of the MFGM isolate, selecting an appropriate amount to add 
to the diets to achieve a 0.1% (w/w) sphingomyelin concentration, and then adjusting the 
other nutrients accordingly.  The measurement of protein, total fat, ash and lactose were 
conducted as previously described (21).  Ash was further analyzed for specific minerals 
by inductively coupled plasma spectroscopy (ICP-AES) at a core facility on the Utah 
State University campus.  The composition of the three experimental diets is shown in  
Table 2.  
Animals and Diets 
Sixty-three male, weanling Fischer-344 rats (Charles River Laboratories) were 
randomly assigned to one of three dietary treatments that differed only in the fat source as 
previously described.  The diets were based on the AIN-76A rodent diet, and the fat 
sources were a) corn oil, b) anhydrous milk fat, and c) a combination of AMF and 
MFGM.  After a 7-day acclimation period on standard chow diets, the rats were 
individually housed in a room controlled for temperature, humidity, and light cycle and 
were given free access to experimental diets and deionized water.  Food intake and 
weight were measured weekly, and the animals were monitored for signs of disease.  All 
experimental protocols involving animals were approved by the Utah State University 
Institutional Animal Care and Use Committee. 
 Animals were fed experimental diets for three weeks and then injected 
(intraperitoneal) with 1,2-dimethylhydrazine (25 mg/kg of body weight, Sigma) in 
10	  
Table 2: Composition of Dietary Treatments 
   Controla AMFa MFGMa 
Protein (g/kg diet) 
Casein  183 183 183 
Whey  17 17 17 
DL-Methionine  3 3 3 
Carbohydrateb(g/kg diet) 
Sucrose  495 495 495 
Lactose  5 5 5 
Cornstarch  150 150 150 
Cellulose  50 50 50 
Fat (g/kg diet) 
Corn Oil (Control)  50 - - 
AMF  - 50 25 
MFGM isolatec  - - 25 
Vitamins & Mineralsd(mg/kg diet) 
Vitamin Mix  10000 10000 10000 
Zn 30 30 30 (12.6)e 
Mg 507 507 507 (24.6)e 
Ca 5000 5000 5000 (88)e 
P 1561 1561 1561 (14.5)e 
Cu 6 6 6 (2.5)e 
Choline Bitartrate  2000 2000 2000 
Sphingolipid Content (% by weight) 
Sphingomyelin 0.03% 0.03% 0.11% 
aDiets were prepared by Dyets.com. bFour grams of lactose were added to the control 
and AMF diets to balance lactose in MFGM isolate. cMFGM isolate is 68% protein, 
20% fat, 4% ash, and 4% lactose. The casein to whey ratio is 80:20. The triglyceride to 
polar lipid ratio is 60:40. dMineral composition of MFGM isolate was determined by 
ICP-AAS. Minerals were adjusted in MFGM diet accordingly. eAmount derived from 
MFGM portion of the diet in parentheses (mg/kg diet). 
  
phosphate-buffered saline with 1 mmol/L EDTA (Sigma) once per week for two 
consecutive weeks.  Seventeen or sixteen rats per treatment were injected with the 
carcinogen, and four rats per treatment were injected with a saline vehicle control.  The 
colonic mucosa, red blood cells and plasma from these animals were used for gene 
expression studies and fatty acid analysis.  Following injections, animals were fed 
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experimental diets for nine additional weeks.  After MRI analysis of body composition 
(EchoMRI-900™), rats were sacrificed by cardiac puncture and exsanguinations 
following ketamine/xylazine anesthesia.  Tissues and organs (except lower bowel) were 
removed, flash frozen in liquid nitrogen, and stored at -80 °C for future analysis.  The 
lower bowel was removed, washed with saline, split open, laid flat, and stored in 70% 
ethanol at 4 °C.  To avoid bias, colons were randomized and ACF in the entire colon  
were counted by light microscopy following staining with methylene blue. 
RNA Isolation and Gene Expression 
Mucosal cells from animals injected with the vehicle control were obtained by 
scraping saline-washed, split colons with a glass slide, and then flash frozen in liquid 
nitrogen.  Mucosal scrapings were homogenized in Trizol with a tissue homogenizer, and 
total RNA was extracted using the RNAqueous kit (Ambion) according to the 
manufacturer’s protocol.  Total RNA was frozen and sent to Genome Quebec for analysis 
using the Illumina platform (Illumina, Inc.).  Results were analyzed using a software 
analysis program, FlexArray, developed by Genome Quebec to normalize data.  Data was 
then subjected to pathway analysis using Panther (SRI International).  Pathway analysis 
did not reveal differentially regulated cancer pathways that might explain fewer aberrant  
crypts in MFGM fed animals compared to the control and AMF treatments.  
Lipid Profiling 
Lipids were quantified in diets, plasma, red blood cells, and mucosa using a 
combination of thin layer chromatography separation and gas chromatographic analysis 
of fatty acid methyl ester derivatives (FAMEs).  Lipids were extracted using the method 
12	  
of Folch (32), and separated on silica TLC plates according to the method of Watkins 
(33).  Bands were visualized using the fluorescent dye primulin (34), and scraped from 
the TLC plates into 4 mL vials fitted with Teflon caps.  FAMEs were prepared according 
to the method of Curtis (35)  and analyzed using a Shimadzu GC-2010 equipped with a 
BPX-70 capillary column (10m × 0.1 mm i.d. × 0.2 µm film thickness, SGE Inc., Austin, 
TX).  One microliter of sample was injected out of a volume of 100 µL. The injector was 
maintained at 250 ºC and all samples were injected in split mode (triglyceride samples at 
a 250:1 ratio and all other samples 25:1). Hydrogen was used as the carrier gas at a linear 
velocity of 56.4 cm/s, the total flow was 16 mL/min with a 3mL/min purge flow.  The 
oven program was as follows: initial temperature of 50 ºC for 0.29 min, 82 ºC/min ramp 
to 180 ºC, hold for 1.45 min, ramp at 13.8 ºC/min to 220 ºC, ramp to 250 at 35.54 ºC/min, 
hold for two minutes.  The detector was maintained at 250 ºC; the detector gasses were as 
follows: air at 400 mL/min; hydrogen at 39 mL/min.  Total run time was 9.04 min.  Fatty 
acids were identified according to retention time to authentic standards, and quantified  
using surrogate spikes and experimentally determined response factors. 
Statistical Analysis 
Differences in feed intake, body weight, body composition, ACF, lipid profiles of 
total plasma triglycerides, total plasma phospholipids, mucosa sphingomyelin and RBCs 
were determined by ANOVA and Fisher’s LSD test.  Significant differences in gene 
expression were determined by FlexArray 1.3 analysis software.  Expression was 
normalized using the lumi method (a pipeline for processing Illumina microarray) and  
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differences in relative gene expression were determined using the EB (Wright & Simon)  
method (36). 
Results and Discussion 
MFGM Composition and Diet Formulation 
The composition of isolated MFGM was 68% protein, 20% fat, 4.5% ash and 4% 
lactose.  It was determined that adding the MFGM isolate at 12.5% of the diet (w/w) 
would supply approximately ½ of the fat in the AIN-76A diet (2.5 % out of 5%) and 
would provide approximately 10% of the fat as membrane lipids with about 0.1% as 
sphingomyelin.  As the MFGM extract also contains a significant portion of milk protein 
(68% of powder with a casein:whey ratio of 8:2), addition of 12.5% MFGM also 
contributed 1.7% whey protein.  To prevent potential confounding effects from different 
protein sources, we adjusted the control diet and AMF diet to also contain 1.7% whey 
protein.  Additionally, some of the proteins of the MFGM powder are membrane proteins 
associated with the material itself.  Compositional analyses of highly purified MFGM 
indicate the material is approximately 50% protein and 50% lipid (37).  Therefore, the 
contribution of MFGM membrane proteins to the MFGM diet may be as high as 12.5% 
of protein, and were unique to this diet.  We also adjusted the carbohydrate content of the 
control and AMF diets to accommodate a small amount of lactose in the MFGM powder.  
Finally, we balanced diets to account for the mineral profile of MFGM powder, see Table 
2 for diet compositions. 
Upon receipt, the diets were analyzed for total fatty acid composition (Table 3), 
phospholipid composition, and sphingomyelin content (Table 2).  As was planned, the  
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Table 3: Fatty Acid Composition of Diets (%) 
  Control AMF MFGM 
C4:0 0 1.8 2.7 
C6:0 0 2.4 2.5 
C8:0 0 1.7 1.6 
C10:0 0 3.5 3.3 
C12:0 0 3.8 3.3 
C14:0 0.5 11.6 10.3 
C15:0 0.1 1 1 
C16:0 11.4 27.3 27.4 
C16:1 n7 0.2 1.9 1.6 
C18:0 2.2 10.5 11.5 
C18:1 n7t 0.1 2.6 2.7 
C18:1 n9 27.4 24.3 23.6 
C18:2 n6 56.4 4 4.8 
C18:2 9c, t11  0 0.6 0.5 
C18:3 n3 1.0 0.6 0.51 
 
MFGM powder contributed approximately 10% phospholipids (0.53% w/w of diet) to the 
lipid fraction, of which sphingomyelin made up 20% (or 0.11% w/w of diet).  One 
surprising finding in the diet analysis was that the sphingomyelin concentration of the 
control and AMF diets was not insignificant (0.03% w/w for both diets).  As the values 
are the same and as the fatty acid profiles of the sphingomyelin are the same despite the 
different fat sources, we conclude that sphingomyelin is likely contributed by either the 
casein or the whey, or a combination of both.  Nonetheless, previous studies have found 
significant effects with such low levels of sphingomyelin, and therefore the protective  
effects provided by MFGM in this study may be somewhat underestimated. 
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Effect of Diet on Consumption, Weight  
Gain and Body Composition 
Dietary treatment did not significantly affect consumption or weight gain.  MRI 
analysis of whole animals indicated no significant effect on body fat percentage (Figure  
1).  Given that feed intake can affect carcinogenesis, confounding factors are possible  
 
Figure 1.  Effect of experimental diets on consumption (A), total weight gain (B) 
and body fat composition (C).  Values are means (n=17 control diet, n=16 anhydrous 
milk fat diet, n=16 milk fat globular membrane diet) ± standard deviation.  Significant 
differences were determined by ANOVA.  Experimental diets did not significantly affect  
consumption, weight gain or body fat percentage.    
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when feeding different diets even though the diets are isocaloric.  Since the difference in 
fat source between the three diets used in this study did not affect consumption, weight  
gain or body fat, feeding behaviors in each group cannot account for differences in ACF. 
Effect of Dietary Treatment on  
Appearance of ACF 
The ACF model is a well established model of colon cancer and has been used 
extensively in nutritional studies (9-11, 38-41).  Rats fed the MFGM (n=16) diet had a 
significantly reduced number of ACF (P<0.005) compared to the control (n=17) (20.9 ± 
5.7 vs. 31.3 ± 9.5) and AMF (n=16) diets (29.8 ± 11.4), and ACF was not significantly 
different between control and AMF treatments (Figure 2-A).  Dietary treatment had no  
effect on ACF size (Figure 2-B) nor was there a significant difference in the number of  
 
Figure 2.  Effect of experimental diets on (A) 1,2-dimethylhydrazine induced 
aberrant crypt foci (ACF) and (B) ACF size. Values are means (n=17 control diet, n=16 
anhydrous milk fat diet, n=16 milk fat globular membrane diet) ± standard deviation.   
Significant differences were determined by ANOVA and Fisher’s LSD test.  
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ACF with four or more crypts/focus (data not shown) possibly suggesting that MFGM 
treatment is more relevant to preventing ACF initiation as opposed to ACF growth  
progression.  
Effect of Diet on Mucosal Gene Expression 
Out of 21,792 genes, a total of 417, 450, and 321 genes were differentially 
regulated with significance in the mucosa between the MFGM and control, AMF and 
control, and MFGM and AMF dietary treatments, respectively (Figure 3). Despite the  
observation that MFGM treatment decreased ACF compared to both control and AMF;  
no common gene regulation was observed between MFGM vs. control and AMF. 
 
Figure 3.  Venn diagram of differentially regulated genes in the mucosa between 
dietary treatments.  Out of 21,792 genes, a total of 417, 450, and 321 genes were 
differentially regulated with significance in the mucosa between the MFGM vs. control, 
AMF vs. control, and MFGM vs. AMF dietary treatments, respectively.  See Tables 4-10 
(Appendix A) for a listing of the most differentially regulated genes between treatments.     
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Although dietary treatment did not influence the expression of common colon 
cancer genes; sphingomyelin and MFGM’s ability to regulate post-transcriptional gene 
expression cannot be completely ruled out.  A recent study demonstrated that 
sphingomyelin treatment did not significantly alter mRNA levels but had a significant 
effect on protein levels of genes critical to the early stages of colon cancer, such as, beta-
catenin, connexin-43 and Bcl-2 (42).  Our results together with these recent findings 
suggest that the sphingolipids present in the MFGM may not be regulating transcription 
but may be regulating specific post-transcriptional events to reverse aberrant expression 
of individual proteins involved in colon carcinogenesis.  Because many of the 
phospholipids found in MFGM are common second messengers, future studies utilizing 
pathway analysis and proteomics to examine any relationships between MFGM and  
relevant metabolic pathways are needed. 
Effect of Diet on Tissue and Plasma Lipids 
The fatty acid composition of the AMF and MFGM diets were very similar at the 
fatty acid level and very different from that of the control diet (Table 3).  To determine 
how the fatty acids in the three diets affected tissue levels, we measured the fatty acid 
compositions of the red blood cells (RBC) as well as the mucosa (Figure 4).  According 
to the data, the RBC fatty acid composition of animals reflected that of the diet, while the 
mucosa did not.  Several notable differences are apparent in the RBCs.  For example, the 
animals fed the control diets had a lower percentage of oleic acid (C18:1n9) in RBCs 
despite the fact that there was more of this fatty acid in the diet on a percentage basis.  In 
addition, there were significant differences in the metabolism of the n6 and n3 essential  
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Figure 4.  Effect of experimental diets on fatty acid profile of (A) red blood cells 
and (B) mucosal sphingomyelin.  Samples were taken from saline injected control 
animals (n=4 control diet, n=3 anhydrous milk fat diet, n=4 milk fat globular membrane 
diet).  Values are the mean percent of total fatty acids ± standard deviation.  Significant 
differences were determined by ANOVA and Fisher’s LSD test.  Differently lettered 
columns are significantly different (P<0.05).  Red blood cell fatty acids that comprise  
less than 1% of total fatty acids are not shown.  
fatty acids.  For example, the RBCs of the animals fed the control diets were enriched in 
linoleic acid (C18:2n6) and its elongation and desaturation products arachadonic acid 
(C20:4n6) and docosatetraenoic acid (C22:4n6).  The animals fed the AMF and MFGM 
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diets, on the other hand, had greater RBC fatty acid proportions of docosapentaenoic acid 
(C22:5n3) and docosahexaenoic acid (C22:6n3) despite the fact that the overall 
percentage of n3 fatty acid contribution to the diet was lower (1.0% for control diet vs. 
0.8% for both AMF and MFGM diets).  It has been hypothesized that high tissue levels of 
arachadonic acid may affect susceptibility to cancer via inflammatory signaling (43). 
However, our results do not indicate there is any effect as the animals fed the AMF and 
the control diets had similar levels of ACF.  
We hypothesized that the higher content of spingomyelin in the MFGM would 
affect the mucosal spingomyelin fatty acid profile. As sphingomyelin is thought to be  
slowly digested along the length of the digestive tract (8), it stands to reason that it may 
be available in the gut lumen for absorption by the epithelia.  Alternatively, as was noted 
with RBCs, if absorbed, sphingomyelin might also be provided to the mucosa via the 
systemic circulation.  However, unlike RBCs, the sphingomyelin profile of the colonic 
mucosa was not significantly affected by the differences in dietary fatty acids (Figure 4).  
According the diet analysis, the sphingomyelin fatty acids most abundant in the MFGM 
diet, compared to the control and AMF diets, were C16:0, C22:0, C23:0 and C24:0 (data 
not shown).  Yet, the sphingomyelin of the MFGM diets does not seem to be enriched in 
the longer chain species, although there is a small effect with C16:0 (Figure 4). 
Plasma triglycerides differed significantly only between animals fed the AMF 
(1,634 µg/mL plasma ± 477) and MFGM (3,666 µg/mL plasma ± 703; P<0.02) dietary 
treatments (Figure 5).  Plasma phospholipids were significantly different in animals fed 
the AMF (640 µg/mL plasma ± 35) diet from those fed the control (1,025 µg/mL plasma 
± 194; P<0.04) and MFGM (1,069 µg/mL plasma ± 194; P<0.04) diets; however, no 
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Figure 5.  Effect of diet on fatty acid profile of (A) plasma triglycerides, (B) 
plasma phospholipids, (C) sum total of plasma triglycerides, and (D) sum total of 
phospholipid fatty acids.  Samples were taken from saline injected control animals (n=4 
control diet, n=3 anhydrous milk fat diet, n=4 milk fat globular membrane diet).  Values 
are means (µg fatty acids/mL plasma) ± standard deviation.  Significant differences were 
determined by ANOVA and Fisher’s LSD test.  Differently lettered columns are 
significantly different (P<0.05).  Triglyceride fatty acids with values less than 0.5 µg/mL 
and phospholipid fatty acids with values less than 10 µg/mL are not shown.   
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significant difference was seen between the animals fed the control and MFGM diets 
(Figure 5).  Despite the similar fatty acid profiles of MFGM and AMF diets, they have 
very different effects on plasma triglycerides and phospholipids that are not related to 
differences seen in cancer protection. 
 Our results support the hypothesis that diets containing MFGM are protective 
against colon cancer in Fischer-344 rats, perhaps because of MFGM’s high polar lipid 
content, namely, sphingomyelin.  By incorporating MFGM into the diet, animals were 
provided (0.11% w/w) sphingomyelin.  Previous studies using sphingomyelin 
concentrations ranging from 0.025% to 0.1% sphingomyelin (by weight) have clearly 
shown sphingomyelin’s role in the prevention of colon carcinogenesis (9-11, 37, 42); 
however many of those studies used a very pure form of isolated sphingomyelin.  In this 
study, the sphingomyelin is in a more practical form or more similar to how it would be 
incorporated into human diets, and the MFGM contains other important phospholipids 
such as phosphatidylcholine and phosphatidylethanolamine.  One other major difference 
in the MFGM diet, compared to the control and AMF diets, was the contribution of 
MFGM proteins.  Several of these membrane proteins have been hypothesized to provide 
biological effects, and we cannot rule out the fact that they may have contributed to the 
protective effect of the diet.  In pilot studies conducted in vitro, we noted that these 
proteins are extensively proteolyzed by a combination of stomach and pancreatic 
proteases, but this does not rule out bioactivity mediated by the peptide fragments.  Thus, 
the contribution of these proteins remains unknown.  The results of this study 
demonstrate that MFGM, a readily available byproduct from dairy processing, can be 
incorporated into diets and is protective against colon cancer. 
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CHAPTER III 
DIETARY MILK FAT GLOBULE MEMBRANE PROVIDES PROTECTION 
AGAINST GASTROINTESTINAL STRESS IN MICE TREATED WITH  
LIPOPOLYSACCHARIDE 
Introduction 
Inflammation causes increased intestinal permeability and gut barrier integrity is 
compromised leading to dysfunction (1).  While the mechanism of how gut barrier 
dysfunction occurs is unclear, pro-inflammatory cytokines, such as, IL-4, IL-13, IFN-γ, 
and TNF-α, have been reported to increase the permeability of intestinal epithelia (2-4).  
Several studies suggest that various milk sphingolipids, including sphingomyelin and 
gangliosides, positively affect the gut by exhibiting a protective effect against colon 
cancer (5-9), and other studies have linked sphingolipids and other milk fat fractions 
containing phospholipids and gangliosides to the inhibition of a pro-inflammatory 
response and gut barrier protection (10-14). 
One source of a variety of sphingolipids is the milk fat globule membrane 
(MFGM) which is a protein-lipid complex originating from the apical surface of 
mammary epithelial cells and surrounds the fat globules in milk.  During milk synthesis, 
fat droplets originate in the endoplasmic reticulum and travel directly to the cell’s apical 
surface.  As they travel from the epithelial cells into the alveolar lumen, they pass 
through the apical membrane and are encapsulated in the plasma membrane complete 
with the exterior glycocalyx resulting in discrete globules (15).  These milk fat globules 
range in diameter from 0.1 to about 15 µm (16), and have a nonpolar lipid core that is 
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surrounded by the MFGM containing phospholipids and membrane glycoproteins (major 
components of MFGM are found in Table 1). 
While MFGM is in all dairy products, churn buttermilk, a co-product of butter 
production, is especially enriched with it.  When milk fat is churned, the membrane 
surrounding the fat globules is disrupted, and the free fat released from the globules 
coalesces.  This process ultimately results in a solid fat phase, butter, and an aqueous 
phase, also known as churn buttermilk.  This material, buttermilk, has a long history of 
anecdotal health-promoting associations, yet it does not currently generate any added 
value in the market place for delivering nutritional benefit.  However, MFGM has 
recently been shown in lipidomic and proteomic characterizations to have an interesting 
carbohydrate, lipid and protein profile (17-19), and the phospholipids and membrane 
glycoproteins found in MFGM likely interact extensively with the gut epithelia during 
digestion, both physically and biochemically.  Its unique composition has led to the idea 
that MFGM could have remarkable nutraceutical properties (20), and various research 
groups are conducting studies to ease its recovery from buttermilk (20-32). 
Although MFGM’s recovery is well documented, very few studies have been 
conducted to determine any nutritional benefits of MFGM, although some indicate 
beneficial effects of its components.  One study demonstrated that milk fat globule–EGF 
factor-8/lactadherin, a major protein component associated with MFGM, is an important 
factor in maintaining epithelial homeostasis and mucosal integrity of the intestinal tract 
(33), and other groups have demonstrated the MFGM-derived polar lipids improve the 
resistance of epithelia to stress (34-35). 
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We investigated whether diets containing MFGM will promote gut mucosal 
integrity in BALB/c mice challenged with lipopolysaccharide (LPS).  LPS induces an 
inflammatory response mimicking gastrointestinal injury (1), and has been used in 
numerous studies to emulate the inflammatory response seen in gram negative bacterial 
infections.  Because of MFGM’s phospholipid enrichment and unique biochemical 
nature, we hypothesized that diets providing MFGM as a fat source might protect against 
an exaggerated inflammatory response and corresponding compromised gut barrier  
integrity. 
Materials and Methods 
Isolation of Milk Fat Globule Membrane 
 Sweet cream was obtained from Cal Poly Dairy Farm milk by centrifugation after 
pasteurization.  It was churned after a waiting period of 16 h at 4 °C using a continuous 
pilot scale butter churn (Egli AG, Bütschwil, Switzerland).  Buttermilk was recovered 
and butter fines were removed by filtration through cheese cloth. 
A pilot plant scale system (R-12 model, GEA-Niro Filtration, Hudson, WI,) using 
two spiral polymeric membranes fitted in parallel on the module (10 kDa molecular 
weight cutoff, 11.33 m2 total surface area) was used for buttermilk concentration.  The 
process was carried out at 25 °C, the transmembrane pressure was 6 bar and the feed 
pump was operated at 35 Hz.  The ultrafiltration was conducted until a 10-fold 
volumetric concentration factor was reached.  Diafiltration was completed by adding tap 
water continuously at 25 °C to the feed tank to replace the removed permeate until 
reaching a 5-fold diafiltration factor.  In each step of the filtration, samples of retentates 
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were collected for composition analysis and the permeate flux was measured.  The final 
retentates were spray-dried (Niro Filterlab Spray-drier, Hudson, WI,) to obtain whey  
buttermilk powders. 
Diet Formulation  
Diets were formulated to differ only in the composition of the fat. The control diet 
contained 5% fat provided as corn oil.  The MFGM diet also contained 5% fat, but half of 
the fat for the MFGM diet was provided as anhydrous milk fat and half was provided as 
MFGM isolate.  MFGM isolate is approximately 60% triglycerides and 40% polar lipids.  
Besides dietary fat source, both diets were identical in macro and micro nutrients.  The 
measurement of protein, total fat, ash and lactose were conducted as previously described 
(27).  Ash was further analyzed for specific minerals by inductively coupled plasma 
spectroscopy (ICP-AES) at a core facility on the USU campus.  The composition of the  
two experimental diets is shown in Table 2. 
Animals and Diets 
To test the hypothesis that MFGM confers protective effects against LPS induced 
inflammation and improves gut barrier protection; a 2 Х 2 factorial design was used. 
Weanling, male BALB/c mice (n=24/time point) were randomly assigned to one of the 
following treatments: 1) control diet (AIN-76A), saline vehicle control injection (n=6); 2) 
control diet, LPS injection (n=6); 3) MFGM diet (AIN-76A with milk fat), saline vehicle 
control injection (n=6); or 4) MFGM diet, LPS injection (n=6) (Figure 6).  Mice were fed 
experimental diets for five weeks.  This timeframe is precedented by a previous 
investigation examining dietary Zn and LPS induced inflammation (36).  On day 35, 
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Figure 6.  A 2 Х 2 experimental design of treatments was used for each time point 
(24 h and 48 h). Subjects (n=24) were randomly assigned to one of the following 
treatments: 1) control diet (AIN-76A), saline vehicle control injection (n=6), 2) control 
diet, LPS injection (n=6), 3) control + 10% MFGM diet, saline vehicle control injection  
(n=6), or 4) control + 10% MFGM diet, LPS injection (n=6). 
mice were injected intraperitoneally (i.p.) with a dose of saline vehicle control or LPS (10 
mg/kg body weight) known to induce inflammatory cytokines and compromise gut 
barrier integrity.  This dose of LPS (i.p.) has previously been shown to induce monocyte 
adhesion and infiltration into intestinal tissues of mice and induce intestinal distress (36).  
To assess intestinal permeability, mice were gavaged with 4000 Da Dextran-FITC 
(Sigma) suspended in PBS immediately after vehicle control or LPS injection (37).  After 
injection and gavage, animals were serially harvested at 24 h and 48 h by CO2 
asphyxiation.  In a preliminary study we saw no changes in the appearance of plasma 
fluorescence after LPS injection at 0 and 12 h with peak fluorescence occurring at 24 h 
(data not shown).  These time points and animal numbers have been used successfully to 
determine statistical differences in membrane integrity (37).  Serum, liver, femur, and 
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muscle samples were taken and stored for future analysis.  All experimental protocols 
involving animals were approved by the Utah State University Institutional Animal Care  
and Use Committee. 
Gut Barrier Integrity Analysis    
To assess gut barrier integrity, serum samples from all time points were assayed 
for dextran-FITC (Amersham Typhoon Trio+® and ImageQuant© TL software, GE 
Healthcare Bio-Sciences, Uppsala, Sweden). Dextran-FITC permeation of the gut has 
shown to be a sensitive indicator of gut barrier integrity in vivo and serum dextran-FITC  
levels are positively correlated with intestinal insult (37).   
Serum Cytokine Analysis 
Serum cytokine analysis was performed on samples from all time points using the 
Q-Plex™ Mouse Cytokine - Screen (16-plex) array (Quansys Biosciences, Logan, UT, 
USA).  Cytokines analyzed include: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-
12p70, IL-17, MCP-1, IFNγ, TNFα, MIP-1α, GMCSF, and RANTES.  LPS has been 
shown to elevate serum concentrations of various cytokines in mice, specifically IL-6, IL- 
10, IL-12, MCP-1, IFNγ, and TNFα (38).  
Statistical Analysis 
Differences in diet consumption, body weight, serum fluorescence and serum  
cytokine concentrations were separated by Student’s t-test. 
 
35	  
Results and Discussion 
Effect of Diet on Consumption and  
Weight Gain 
 Weight and food intake was measured weekly.  Dietary treatment did not 
significantly affect consumption or weight gain of animals (Figure 7).  Because no 
significant differences were seen in feeding behavior and weight gain of mice between 
the two diets, we can confidently assume body composition was similar and did not  
account for any of the differences seen in gut permeability or cytokine induction. 
 
Figure 7.  Effect of experimental diets on consumption (A) and total weight gain 
(B).  Values are means (n=36 control diet, n=33 MFGM diet) ± standard deviation. 
Experimental diets did not significantly affect consumption or weight gain of each  
animal. 
Effect of Diet on Gut Barrier Integrity 
 Analysis of dextran-FITC levels in serum showed that gut permeability decreased 
significantly at 24 h in animals fed MFGM diet (MFGM diet/LPS/24h: 5.92 ± 0.59 
µg/mL) versus control diet (control diet/LPS/24h: 10.8 ± 0.18 µg/mL; P<0.05) when 
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challenged with LPS, which is a 45% decrease.  Animals injected with the vehicle control 
had the same serum fluorescence levels of LPS challenged animals fed the MFGM diet at 
24 and 48 h (control diet/saline/24h: 6.37 ± 1.29 µg/mL; control diet/saline/48h: 5.63 ± 
0.39 µg/mL; MFGM diet/saline/24h: 5.80 ± 0.31 µg/mL; MFGM diet/saline/48h: 5.75 ± 
0.46 µg/mL; MFGM diet/LPS/48h: 5.68 ± 0.55 µg/mL).  All animals fed control diet and  
challenged with LPS died before the 48 h time point (Figure 8). 
 
Figure 8.  Effect of experimental diets and treatments on gut permeability at 24 
and 48 h.  Serum fluorescence levels of LPS challenged mice fed MFGM diet did not 
differ significantly from those receiving vehicle injection but were significantly lower 
(P<0.05) than LPS challenged mice fed control diet at 24 h.  Data are mean dextran- 
FITC concentrations ± standard deviations. 
Serum fluorescence of animals fed control diet and challenged with LPS was 
significantly higher than animals fed MFGM diet and challenged with LPS, illustrating 
that MFGM plays a role in protecting against gastrointestinal injury.  Also, animals fed 
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MFGM diet and challenged with LPS had serum fluorescence levels that did not differ 
significantly from animals fed control and MFGM diets receiving vehicle injections,  
further demonstrating MFGM’s protective effect on gut barrier integrity. 
Effect of Diet on Serum Cytokines 
 At the 24 h time point, six of the 16 total cytokines had a significantly lower 
serum concentration among animals fed the MFGM diet versus the control diet.  IL-6 was 
the most significant difference (2.24 pg/mg serum protein ± 0.34 vs. 4.00 pg/mg serum 
protein ± 0.42; P<0.002).  Other serum cytokine concentrations that were significantly 
lower were IL-10 (3.12 fg/mg serum protein ± 0.04 vs. 3.61 fg/mg serum protein ± 0.30; 
P<0.04); IL-17 (2.79 fg/mg serum protein ± 0.60 vs. 3.71 fg/mg serum protein ± 0.64; 
P<0.03); MCP-1 (1.90 pg/mg serum protein ± 0.67 vs. 3.07 pg/mg serum protein ± 0.83; 
P<0.05); IFNγ (2.87 fg/mg serum protein ± 0.29 vs. 4.13 fg/mg serum protein ± 0.61; 
P<0.025); TNFα (2.47 fg/mg serum protein ± 0.12 vs. 3.21 fg/mg serum protein ± 0.40; 
P<0.03); and IL-12p70 (2.67 fg/mg serum protein ± 0.02 vs. 3.52 fg/mg serum protein ± 
0.24; P<0.002) (Figure 9).  Serum concentrations of IL-3 were below the detection limit 
at 24 h and 48 h (Figure 9).  Serum cytokines did not differ significantly in any of the 
following cytokines at 24 h: IL-1α, IL-1β, IL-5, MIP-1α, GMCSF, and RANTES (Figure 
10).  Cytokines IL-2 and IL-4 were not affected by LPS challenge (data not shown). 
During inflammation, cytokines are released in response to trauma as represented 
by the control diet with LPS challenge.  The decreased serum levels of several cytokines 
in mice fed the experimental diet suggest that MFGM reduces the inflammatory response 
following stress.  Our results are consistent with those investigating the effects of 
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Figure 9.  Significant effects of dietary treatment on serum cytokine levels after 
LPS challenge at 24 and 48 h.  All animals fed control diet and challenged with LPS died 
before the 48 h time point.  (A) IL-6, (B) IL-10, (C) IL-17, (D) MCP-1, (E) IFNγ, (F) 
TNFα, and (G) IL-12p70 all had significantly decreased serum concentrations 24 hours 
after LPS Challenge.  (H) IL-3 serum concentrations were below the detection limit after 
the 24 and 48 h time points.  Data are log10 transformed mean cytokine 
concentrations/mg serum protein ± standard deviations.  The significance of the 
differences from control diet (24 h) were: *P<0.05; and **P<0.005. 
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Figure 10.  Effects of dietary treatment on serum cytokine levels after LPS 
challenge at 24 and 48 h.  All animals fed control diet and challenged with LPS died 
before the 48 h time point.  (A) IL-1α, (B) IL-1β, (C) IL-5, (D) MIP-1α, (E) GMCSF, and 
(F) RANTES did not have significant changes in serum concentrations 24 hours after 
LPS challenge.  Data are log10 transformed mean cytokine concentrations/mg serum 
protein ± standard deviations.  The significance of the differences from control diet (24 h)  
was: *P<0.005. 
sphingolipids and gangliosides on inflammation (10-13), suggesting that the high 
sphingolipid content of MFGM could be responsible for the lowered inflammatory 
response. 
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 Gut barrier dysfunction has been identified as a result of cytokine induction due to 
inflammation (39).  As adhesion molecules are expressed on the endothelial membrane 
surface, inflammatory mediators are produced and released which compromise gut 
barrier integrity by interacting with the circulating leukocytes (40).  Our results suggest 
that MFGM as a dietary component plays a role in protecting against intestinal 
permeability by controlling the inflammatory response, causing the gut barrier to remain 
better intact. 
 In conclusion, after treatment with LPS, we saw that MFGM dietary treatment led 
to a 45% decrease in gut permeability and significant differences of serum cytokine 
levels in eight of the 16 cytokines analyzed when compared to control dietary treatment.  
Our results imply that MFGM, a by-product of dairy processing, is protective against 
gastrointestinal stress.  Possible mechanisms for its protection are the increased polar 
lipid content of the MFGM diet and the inhibition of several cytokines during the  
inflammatory response, leading to increased gut barrier integrity.  
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 MFGM is a complex biopolymer.  It contains various protein and lipid 
components that have been shown to exhibit beneficial properties in the gut.  To date, no 
other studies have examined the effects of dietary MFGM as a whole dietary component 
on cancer, contributing to the novelty of the study.   
The results of this study support the hypothesis that dietary MFGM protects 
against colon cancer in rats.  Although no differences were seen in candidate 
carcinogenesis gene mRNA levels by microarray analysis, we cannot rule out the 
suggestion that MFGM affects gene regulation.  A recent study demonstrated that 
sphingomyelin (a major component of MFGM) did not alter mRNA levels but had a 
significant effect on protein levels of genes critical to the early stages of colon cancer.  
Animals receiving the MFGM dietary treatment were provided with three to four times 
the amount of sphingomyelin compared to animals receiving control or AMF dietary 
treatments (0.11% vs. 0.03% w/w).  The high polar lipid content and unique protein 
profile of MFGM likely contributed to the beneficial effects. 
The results of this study also support the hypothesis that dietary MFGM protects 
against gastrointestinal stress in mice.  Gut permeability, a common condition during 
gastrointestinal stress, was significantly lower in animals challenged with LPS receiving 
the MFGM dietary treatment compared with those receiving control dietary treatment.  
This effect is most likely due to the inhibition of the inflammatory response seen in 
animals receiving the MFGM dietary treatment, although the mechanism of how dietary 
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MFGM inhibited the inflammatory response is not yet understood.  Many of the polar 
lipids and proteins found in MFGM have been shown to encourage mucosal integrity, 
maintain epithelial homeostasis and improve the resistance of epithelia to stress; 
therefore, MFGM’s high polar lipid content and unique protein profile likely contribute 
to its decrease in gut permeability. 
Through the course of the study, we demonstrated that MFGM can be 
incorporated into diets.  Also, as a dietary component, MFGM plays a role in a protection 
mechanism against colon cancer and gastrointestinal stress. 
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Table 4: Five Most Up- and Down-Regulated Genes between MFGM Diet vs. Control 
Diet. 
 
 
MFGM vs. Control 
 Gene ID 
Fold 
Change P-Value 
Up-regulated 
1 LOC310926 2.355885 0.038176 
2 SCD 1.939384 0.005074 
3 CXCL10 1.521025 0.01754 
4 ZG16 1.511295 0.036695 
5 LOC367047 1.400982 0.038917 
Down-regulated 
1 RGD1565429_PREDICTED 0.640796 0.019673 
2 ANP32A 0.6764068 0.0279 
3 USP45_PREDICTED 0.7445057 0.005818 
4 LOC501281 0.751458 0.045869 
5 CAND1 0.7531238 0.01853 
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Table 5: Significantly Regulated Genes between MFGM Diet vs. Control Diet in the  
Mucosa. 
MFGM vs. Control 
Target ID 
Fold 
change P-value 
LOC310926 2.355885 0.0381762 
SCD 1.939384 0.0050741 
CXCL10 1.521025 0.0175397 
ZG16 1.511295 0.0366953 
LOC367047 1.400982 0.0389167 
LOC363377 1.391373 0.0201462 
HERPUD1 1.375355 0.0111023 
COX7A2L_PREDICTED 1.353644 0.0427468 
PDIA3 1.35131 0.0199033 
RGD1311783_PREDICTED 1.325598 0.0231317 
ISY1 1.31423 0.0475264 
RALY 1.309493 0.0038239 
MAP3K12 1.294607 0.0225792 
KLF9 1.266012 0.0448647 
HNRPD 1.25089 0.0049305 
LOC498644 1.243892 0.0266625 
DDX6 1.242621 0.0254743 
RGD1305689 1.240352 0.0480694 
LOC500378 1.21725 0.0102016 
RPIA_PREDICTED 1.212413 0.0384905 
PSME1 1.212389 0.0446126 
RGD1308706_PREDICTED 1.205986 0.0324779 
TBC1D1_PREDICTED 1.196804 0.0390036 
LOC368001 1.18585 0.0275307 
LOC499427 1.185698 0.0265257 
IL18BP 1.184741 0.0404916 
ZNRD1 1.183265 0.0246914 
FEZ2 1.18264 0.0379384 
NFKB1 1.162584 0.0347342 
RGD1310490_PREDICTED 1.160985 0.023338 
BCL7C_PREDICTED 1.16061 0.0266323 
LOC686087 1.158898 0.0322756 
THAP11_PREDICTED 1.153459 0.0393779 
LUC7L_PREDICTED 1.151046 0.0465693 
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RGD1566093_PREDICTED 1.14454 0.0163998 
SLC16A6 1.144526 0.0456379 
VEGFA 1.143586 0.0465874 
CCDC32 1.140401 0.0011543 
ATAD2_PREDICTED 1.133513 0.0078016 
NDUFV3L 1.132308 0.0499381 
WDR21_PREDICTED 1.130986 0.0300504 
NUB1 1.127061 0.0151152 
TNPO2_PREDICTED 1.126023 0.0306336 
STAT5B 1.124939 0.034276 
PARP3 1.117796 0.0155413 
ASGR2 1.112705 0.0356361 
SNX1 1.112335 0.0216484 
SRD5A2 1.109108 0.0222358 
HOXC4_MAPPED 1.107808 0.0227537 
LOC361128 1.107723 0.0162503 
RAGE 1.105514 0.0270273 
RGD1564379_PREDICTED 1.10044 0.0288561 
LOC361283 1.099904 0.0012409 
RNF41 1.09497 0.0254731 
LYSMD1 1.094239 0.0185435 
LOC686701 1.093778 0.0474696 
LOC500211 1.089332 0.0476385 
DOM3Z 1.085238 0.0253879 
PRL8A4 1.0846 0.0353815 
XYLT1 1.083316 0.0381775 
CARD10_PREDICTED 1.082985 0.0176534 
LOC305332 1.078259 0.0152417 
MOCS1_PREDICTED 1.076597 0.0042698 
RGD1565180_PREDICTED 1.071918 0.0451616 
B4GALT1_MAPPED 1.068807 0.0261814 
RGD1308133_PREDICTED 1.068591 0.0134222 
PIK3R4_PREDICTED 1.067798 0.0286012 
USP24_PREDICTED 1.067043 0.0112115 
RPS6KB2 1.065741 0.0437932 
ACVR1 1.065545 0.0341785 
LOC306792 1.064022 0.0346713 
LOC500853 1.062375 0.0190001 
TINF2 1.062154 0.0448867 
LOC502367 1.061734 0.0231657 
FZD9 1.061287 0.0387664 
KIF2 1.060031 0.0441835 
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CALCB 1.059393 0.0074937 
SEMA4C_PREDICTED 1.059385 0.0203667 
LOC499168 1.05936 0.0025689 
MRPS15 1.059293 0.00875 
LOC498710 1.058444 0.0054424 
RAPGEF4 1.058122 0.0238295 
COMMD7_PREDICTED 1.056921 0.0255728 
LOC502712 1.056768 0.0376317 
ACTL7A 1.056744 0.0350923 
LOC293521 1.05669 0.0384601 
LOC689265 1.056385 0.0287891 
LOC503235 1.056338 0.0025473 
LOC297899 1.05456 0.0198993 
KCNJ11 1.054229 0.0035327 
LOC307660 1.053667 0.0118458 
SP2_MAPPED 1.052878 0.0344016 
AASS_PREDICTED 1.052398 0.0382739 
BHLHB9 1.052391 0.0282044 
LOC503486 1.052119 0.0426022 
MRGPRD 1.050914 0.0306858 
LOC302264 1.050369 0.041232 
RGD1562524_PREDICTED 1.050183 0.0288955 
LOC689039 1.049778 0.0491217 
AMPH 1.049633 0.0180346 
ZNF251_PREDICTED 1.049556 0.0058599 
SOCS3 1.04925 0.0075518 
RGD1565152_PREDICTED 1.048861 0.0444437 
LOC502010 1.048655 0.0176169 
ALX1 1.048336 0.0212282 
RGD1310429_PREDICTED 1.048206 0.0369933 
CPNE9 1.047683 0.0249149 
STX1A 1.046412 0.0160486 
CEACAM12_PREDICTED 1.045897 0.0215863 
DSC3_PREDICTED 1.04525 0.0251642 
RN.22499 1.045224 0.0279025 
RGD1562090_PREDICTED 1.045223 0.0033275 
OLR1125 1.045169 0.0254263 
DZIP1L 1.044991 0.0279605 
LOC499971 1.044935 0.0235925 
ALS2CR7_PREDICTED 1.044396 0.0242123 
LOC502102 1.044247 0.0100272 
CLEC14A 1.044127 0.0395619 
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ENPP6_PREDICTED 1.044012 0.0383053 
LOC499128 1.044004 0.0148081 
LOC503473 1.043876 0.0213225 
CEACAM1 1.043503 0.029348 
RGD1559694_PREDICTED 1.043031 0.042743 
RGD1564340_PREDICTED 1.042814 0.0236012 
BRSK2 1.042792 0.0402352 
PRKAA2 1.04266 0.0160156 
QTRT1 1.042167 0.0370457 
SEPT6_PREDICTED 1.041822 0.0266795 
LOC366342 1.041635 0.0459845 
LOC499285 1.041566 0.0153756 
OLR686 1.041301 0.0099675 
TRPM1 1.041031 0.0218485 
LOC301445 1.040988 0.0487171 
LOC314431 1.040865 0.038982 
LOC362680 1.04083 0.0274795 
FOXL2_PREDICTED 1.040696 0.0276477 
LOC301899 1.040295 0.0381695 
LOC503388 1.040281 0.0225095 
GPR114_PREDICTED 1.040195 0.0485326 
LOC684990 1.039985 0.0161394 
RGD1310708_PREDICTED 1.039914 0.0381108 
OLR303 1.039674 0.0241591 
LOC502455 1.039552 0.0116039 
LOC501402 1.039323 0.0412735 
LOC361275 1.038985 0.0378446 
LOC689035 1.03897 0.0401139 
RN.9561 1.038807 0.0336215 
CSRP3 1.038716 0.0394689 
NT5C1B 1.038511 0.0477988 
RGD1565438_PREDICTED 1.038399 0.0447487 
OLR1418 1.037696 0.016986 
LOC501236 1.037694 0.0283869 
V1RK1 1.037648 0.0487831 
LOC499053 1.037633 0.0379699 
ACYP2 1.037615 0.0235453 
ARHGEF17_PREDICTED 1.037612 0.0155498 
MMP27_PREDICTED 1.037475 0.0256429 
LOC307128 1.037305 0.0366654 
RGD1566031_PREDICTED 1.037284 0.0319176 
RGD1560355_PREDICTED 1.037251 0.0355505 
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TTC7B_PREDICTED 1.037104 0.0422871 
OLR321 1.036759 0.0352327 
RGD1565400_PREDICTED 1.036755 0.0221898 
LOC684886 1.036585 0.0361971 
PCDHB4_PREDICTED 1.036541 0.0149216 
MGAT4C_PREDICTED 1.036259 0.0424671 
RGD1563757_PREDICTED 1.036227 0.0376223 
LOC502768 1.035927 0.0358014 
CDC14B_PREDICTED 1.035781 0.0438436 
SEC61G_PREDICTED 1.035759 0.0470815 
LOC360244 1.035666 0.0263374 
LOC291276 1.035141 0.0326757 
RGD1559890_PREDICTED 1.035061 0.0457634 
LOC501180 1.034375 0.03025 
GALR2 1.034027 0.0411584 
NLGN2 1.034022 0.0262358 
LOC502606 1.033786 0.0340859 
OLR1128 1.033315 0.0402471 
ZFP352_PREDICTED 1.03311 0.0347172 
KRTAP15_PREDICTED 1.032842 0.0327249 
DOS_PREDICTED 1.032776 0.0424418 
PRKG1_MAPPED 1.031841 0.0284458 
LRRC3 1.030913 0.0256426 
EPO 1.030725 0.0449105 
LOC502387 1.030124 0.0466222 
LOC499982 1.030112 0.0431271 
LAMP3_PREDICTED 1.029912 0.0499217 
ZNF213_PREDICTED 1.029647 0.0453936 
USP44_PREDICTED 1.029018 0.0478731 
LOC503125 1.02896 0.0394694 
LOC501654 1.028931 0.0477638 
RGD1566018_PREDICTED 1.028265 0.0475036 
LIF 1.027945 0.0400967 
LOC502805 1.027801 0.0421355 
RGD1563285_PREDICTED 1.026861 0.0405766 
LOC498216 1.026008 0.0433552 
V1RC17 1.025839 0.0486922 
RGD1563188_PREDICTED 1.02333 0.0454735 
OLR444 0.9762563 0.0477205 
LOC681139 0.9720347 0.0395993 
NPY5R 0.9714496 0.0293324 
LOC365868 0.9710578 0.049799 
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TAS2R123 0.9709214 0.0283297 
LOC501617 0.9708661 0.042877 
LOC683813 0.9706099 0.0410717 
RGD1561474_PREDICTED 0.970479 0.0373976 
OLR466 0.9703731 0.0459507 
LOC498929 0.9703382 0.0499335 
LOC688663 0.9701667 0.0162727 
LOC501476 0.9700081 0.0471703 
LOC497714 0.969994 0.0414037 
PDE6A_PREDICTED 0.9696309 0.0259375 
MGAT5B_PREDICTED 0.9695728 0.0309398 
SNN 0.9692517 0.0423586 
LOC499045 0.9691978 0.0499711 
LOC498182 0.9690946 0.0380548 
LOC501074 0.9690575 0.030188 
LOC503069 0.9690153 0.0383661 
LOC365549 0.9685253 0.0354445 
RGD1561277_PREDICTED 0.968302 0.0440206 
LOC497945 0.967774 0.0272727 
RGD1560459_PREDICTED 0.9677182 0.0359331 
FREM2_PREDICTED 0.967488 0.0291163 
LOC500138 0.9671729 0.0268598 
OLR53 0.967011 0.0270523 
PGBD5_PREDICTED 0.9666143 0.0469672 
LOC497744 0.9662648 0.0464552 
LOC361165 0.9660687 0.0205633 
DAO 0.9660259 0.0352689 
OLR184 0.9656614 0.0298924 
RGD1560673_PREDICTED 0.9656508 0.0453429 
RGD1562025_PREDICTED 0.965493 0.0411338 
SYT13 0.9654289 0.046742 
LOC498503 0.9654111 0.0284573 
LOC367747 0.9653077 0.0427464 
LOC689326 0.9651308 0.0496414 
LOC503320 0.9649935 0.038587 
LOC503211 0.964772 0.0378877 
LOC305135 0.9647475 0.0218574 
ADAMTSL5_PREDICTED 0.9646713 0.0383278 
OLR1737 0.9645668 0.0116488 
OLR659 0.9644089 0.0361339 
NG35 0.9636572 0.0433023 
LOC501133 0.9632815 0.0299437 
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CACNA2D2 0.9632204 0.0376593 
LOC367379 0.9630936 0.026757 
LOC498055 0.9629906 0.0231886 
LOC503137 0.9627727 0.0235048 
PHYHIPL 0.9625136 0.0257652 
OXCT2A 0.9623671 0.0352257 
RGD1562710_PREDICTED 0.9623451 0.0381446 
PRSSL1 0.9623221 0.0186543 
RGD1307128 0.9621953 0.0090003 
AKAP14 0.9621212 0.0330996 
LOC315766 0.9620503 0.0413979 
RGD1563528_PREDICTED 0.9619129 0.0084165 
SAP18_PREDICTED 0.9615684 0.036827 
LCT 0.9614301 0.0413859 
RGD1564891_PREDICTED 0.961279 0.0332122 
RGD1559927_PREDICTED 0.9610784 0.0274998 
LOC365969 0.9610112 0.0436924 
RGD1560676_PREDICTED 0.9609183 0.0218638 
CDH11 0.9606475 0.0412381 
SUSD2_PREDICTED 0.9600829 0.0265117 
LOC502803 0.9599839 0.0243628 
RGD1559626_PREDICTED 0.9597545 0.0266645 
LOC498059 0.9595367 0.0269306 
LOC502159 0.9595085 0.0327485 
OLR1609 0.9591764 0.0488166 
LOC302091 0.9590597 0.0240644 
MYBPC3_PREDICTED 0.9587525 0.0209324 
ZFP819 0.9586779 0.030756 
LOC500480 0.9586086 0.0279812 
RGD1559839_PREDICTED 0.9583609 0.0227823 
LOC503048 0.9582301 0.0358944 
PSPN 0.9579714 0.0226584 
RGD1304810_PREDICTED 0.9577159 0.037431 
OLR1631 0.9573357 0.0253524 
RGD1560055_PREDICTED 0.9572741 0.045906 
ZFP275_PREDICTED 0.957011 0.0408712 
RAB4B 0.9568822 0.0099714 
FCHSD1_PREDICTED 0.956766 0.0110775 
RGD1564004_PREDICTED 0.956479 0.0103747 
CXXC6_PREDICTED 0.956429 0.0302185 
LOC682990 0.9561712 0.0332338 
LOC500535 0.9560166 0.0206187 
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LOC309854 0.9558811 0.0241537 
RGD1565951_PREDICTED 0.9556721 0.0241729 
OLR774 0.9554771 0.0077322 
ABCA5 0.9554405 0.0107159 
LOC304104 0.955378 0.0426792 
LDHC 0.9549906 0.0130513 
LOC360669 0.9549571 0.0149794 
SLC26A5 0.9545655 0.0072288 
ARHGEF12 0.9545509 0.0276252 
RPE65 0.9540341 0.0461904 
RGD1565606_PREDICTED 0.9539083 0.0234475 
LOC498646 0.9535142 0.0107064 
LOC498140 0.9533413 0.0363066 
BRUNOL6_PREDICTED 0.9532899 0.008752 
USP33 0.9527709 0.0422886 
HIST1H2AA 0.9525985 0.0351597 
HSD17B1 0.9524867 0.0485391 
LOC307855 0.9523194 0.0251016 
YAP1 0.952287 0.0085756 
CWF19L2_PREDICTED 0.9522387 0.0166292 
LOC498766 0.9518551 0.0029157 
LOC499360 0.9512796 0.036239 
LOC502372 0.9510731 0.0088089 
GMCL1 0.951055 0.0310232 
LOC363408 0.9504737 0.0184225 
POLH_PREDICTED 0.9503443 0.049203 
LOC362659 0.9502694 0.0410234 
RGD1560076_PREDICTED 0.9491089 0.0435513 
LOC304125 0.9483902 0.0095496 
LOC498920 0.9481437 0.0045887 
RGD1308472_PREDICTED 0.947939 0.0242183 
OLR1283 0.9474997 0.0025096 
PCDH11X_PREDICTED 0.9465007 0.0321732 
PAIP2_PREDICTED 0.9463511 0.010002 
RGD1560359_PREDICTED 0.9459797 0.0097005 
LOC501457 0.9454419 0.0192386 
LOC501439 0.9452104 0.0018346 
HOXA2 0.9451603 0.0093882 
TCERG1_PREDICTED 0.9431705 0.0197225 
OLR1616 0.9430662 0.0111251 
OLR860 0.9423639 0.0164358 
TAF5_PREDICTED 0.9420244 0.039315 
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RGD1562409_PREDICTED 0.9410123 0.0168676 
LOC503360 0.940404 0.0485053 
PLA2G4B_PREDICTED 0.9387414 0.0206863 
RGD1564846_PREDICTED 0.9370296 0.0316879 
PSMC6 0.9363213 0.0435423 
MPP7 0.9358859 0.0055804 
MFSD3 0.934404 0.025708 
SPAG7_PREDICTED 0.9337173 0.0373528 
NIPA1_PREDICTED 0.9329075 0.0067518 
ZC3H5_PREDICTED 0.9315909 0.0189979 
NOS1AP 0.9308703 0.0183059 
LRDD_PREDICTED 0.9306238 0.016889 
HRPT2_PREDICTED 0.928731 0.0178484 
CUL5 0.9286092 0.0186919 
BAI2_PREDICTED 0.927788 0.024561 
NIPBL 0.9261614 0.0186056 
LOC310177 0.9252936 0.0010832 
GATAD2A 0.9212821 0.0155613 
LOC305913 0.920261 0.0244492 
FAM152A 0.9201247 0.0304004 
RGD1562231_PREDICTED 0.9197941 0.0222948 
PPM1D_PREDICTED 0.9197364 0.0457769 
BAD 0.9173492 0.0466602 
LOC500626 0.9155337 0.0072815 
RGD1566399_PREDICTED 0.9151899 0.0281159 
TDRD3 0.9142547 0.0345902 
RGD1561881_PREDICTED 0.9124417 0.0041542 
LOC300760 0.9104736 0.013478 
RGD1563508_PREDICTED 0.9095511 0.0174047 
DCLK1 0.9030688 0.0292744 
LOC500828 0.9015955 0.0467855 
RGD1560367_PREDICTED 0.9008299 0.0386065 
SFRS16 0.8994004 0.0336196 
COX6C1 0.8959434 0.0481654 
RGD1561500_PREDICTED 0.8951877 0.0212859 
THRAP5_PREDICTED 0.8939835 0.0255209 
LOC497663 0.8902953 0.0012997 
CPEB2_PREDICTED 0.888753 0.00446 
GNRH1 0.8883134 0.0448579 
FBXO22 0.887688 0.0046953 
SUMO1 0.8870339 0.0107225 
FRAP1 0.8852631 0.0180804 
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PHRF1 0.8817367 0.0404116 
RALGDS 0.8810882 0.0447631 
CEPT1 0.8807142 0.0183802 
GRK4 0.8801668 0.0010146 
RPS6KA4_PREDICTED 0.8796822 0.0015199 
UBE2G1 0.8779835 0.0370637 
RBBP7 0.8751011 0.0490209 
MTERF 0.8716518 0.0093692 
RGD1562123_PREDICTED 0.8712765 0.0401896 
PCF11_PREDICTED 0.8700409 0.0181494 
RGD1565385_PREDICTED 0.8668705 0.0377377 
PHTF1 0.8668048 0.0054681 
BRD2 0.8643259 0.0083576 
PAPD5_PREDICTED 0.8602996 0.0481277 
RGD1561653_PREDICTED 0.8601254 0.0017331 
RSBN1L_PREDICTED 0.8593287 0.0012195 
SACM1L 0.8553795 0.0071806 
LOC309478 0.8524758 6.53E-05 
SMPD1 0.8481247 0.0414284 
RGD1305138_PREDICTED 0.8479513 0.0209713 
CDA08 0.8463009 0.0446314 
IK 0.8436558 0.0190979 
ATXN2L_PREDICTED 0.8387209 0.0182484 
PARG 0.836711 0.0143055 
LOC360975 0.8311789 0.0476032 
DDX20 0.8282401 0.0119589 
MYST2 0.8281819 0.0426826 
NYW1 0.8251221 0.011923 
LOC360910 0.8237457 0.0381603 
EIF5 0.8211176 0.0194536 
LOC498824 0.8111375 4.97E-05 
ZFP68_PREDICTED 0.8087114 0.002433 
ATP6AP1 0.8051428 0.0198644 
ADFP 0.8042018 0.0468284 
LOC498363 0.7986889 0.0395631 
MRLCB 0.7967454 0.0405885 
FRAG1 0.795608 0.0367281 
SAMD4B 0.7931481 0.0197315 
CD2BP2_PREDICTED 0.775653 0.0316987 
DUSP6 0.7645839 0.0043763 
CD63 0.7571203 0.0278014 
NFIB 0.755833 0.0494485 
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CAND1 0.7531238 0.0185297 
LOC501281 0.751458 0.045869 
USP45_PREDICTED 0.7445057 0.0058182 
ANP32A 0.6764068 0.0278996 
RGD1565429_PREDICTED 0.640796 0.019673 
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Table 6: Five Most Up- and Down-Regulated Genes between MFGM Diet vs. AMF Diet. 
MFGM vs. AMF 
 Gene ID 
Fold 
change P-value 
Up-regulated 
1 PSMB8 1.651346 0.045816 
2 LOC499880 1.519122 0.046552 
3 RGD1565117_PREDICTED 1.420793 0.030329 
4 PSMB9 1.374297 0.018845 
5 CD44 1.369928 0.01712 
Down-regulated 
1 THRB 0.6500115 0.002953 
2 STAT6_PREDICTED 0.6881498 0.033623 
3 LOC500586 0.6917345 0.026157 
4 MBC2 0.7300745 0.04275 
5 NCOR1 0.7514342 0.004645 
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Table 7: Significantly Regulated Genes between MFGM Diet vs. AMF Diet in the 
Mucosa. 
 
 
MFGM vs. AMF 
Target ID 
Fold 
change P-value 
PSMB8 1.651346 0.045816 
LOC499880 1.519122 0.046552 
RGD1565117_PREDICTED 1.420793 0.030329 
PSMB9 1.374297 0.018845 
CD44 1.369928 0.01712 
RGD1564423_PREDICTED 1.315448 0.017659 
S100A3 1.309795 0.000716 
RGD1562404_PREDICTED 1.304512 0.019144 
SLC7A5 1.295485 0.049634 
PSME2 1.291194 0.046737 
LOC363418 1.287347 0.027908 
LOC366258 1.265227 0.017611 
OASL2 1.259001 0.023174 
RPL36A 1.256342 0.023611 
RGD1561768_PREDICTED 1.21246 0.001023 
LOC500378 1.192212 0.045204 
ABCF2_PREDICTED 1.19076 0.030949 
DDX41_PREDICTED 1.189989 0.036984 
RGD1562563_PREDICTED 1.182633 0.04668 
LOC498078 1.181407 0.032646 
RGD1311362 1.168489 0.023423 
RGD1311017_PREDICTED 1.168335 0.012874 
CLNS1A 1.167395 0.013585 
RGD1559513_PREDICTED 1.16505 0.020955 
EIF1A 1.163853 0.049729 
RGD1563679_PREDICTED 1.162626 0.012219 
RGD1309747_PREDICTED 1.162143 0.011261 
DHPS 1.158102 0.004284 
TP53 1.156379 0.009508 
NGFRAP1 1.154573 0.00034 
RGD1307234_PREDICTED 1.154401 0.036014 
NFKB1 1.151018 0.024017 
RPIA_PREDICTED 1.14906 0.041196 
HOXC4_MAPPED 1.147466 0.004489 
CRBN 1.146662 0.016597 
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RGD1309095_PREDICTED 1.146183 0.041043 
DHX9_PREDICTED 1.145459 0.007045 
LOC685245 1.14215 0.008091 
IRF8 1.14184 0.021024 
TRIM35 1.14158 0.026285 
RGD1561198_PREDICTED 1.139508 0.020574 
RGD1565165_PREDICTED 1.138292 0.027433 
THOP1 1.134923 0.025221 
TBC1D1_PREDICTED 1.133077 0.048495 
RGD1562469_PREDICTED 1.130461 0.038895 
ZSWIM3_PREDICTED 1.129775 0.020707 
RGD1305500_PREDICTED 1.129631 0.04364 
TCFCP2_PREDICTED 1.12769 0.039915 
COLEC10_PREDICTED 1.12737 0.009009 
RAGE 1.119869 0.014283 
LOC368001 1.118881 0.019808 
ELF2 1.117324 0.014512 
RGD1304621_PREDICTED 1.116242 0.032573 
RGD1564379_PREDICTED 1.111312 0.045168 
RGD1307179_PREDICTED 1.110695 0.014367 
RGD1559846_PREDICTED 1.110518 0.018976 
LOC498557 1.109815 0.002224 
CLEC14A 1.106583 0.037766 
ATAD2_PREDICTED 1.105385 0.024882 
RGD1309188_PREDICTED 1.104923 0.037213 
ALX1 1.103813 0.021745 
SRD5A2 1.103219 0.00159 
RGD1309148_PREDICTED 1.10049 0.042835 
LOC498418 1.100101 0.026676 
MYBPH 1.099664 0.017031 
JOSD2_PREDICTED 1.097741 0.026714 
TRMT1 1.094885 0.029201 
RBBP5_PREDICTED 1.094784 0.046372 
CAPG 1.091008 0.019185 
SFMBT1 1.090861 0.030107 
C20ORF165 1.087963 0.035044 
LOC305332 1.0858 0.013505 
RGD1311526_PREDICTED 1.084837 0.00969 
RNPS1_PREDICTED 1.083305 0.007445 
OLR401 1.081797 0.003058 
EPM2AIP1_PREDICTED 1.081634 0.007014 
LYSMD1 1.08088 0.003445 
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XYLT1 1.079151 0.009505 
LOC292543 1.077932 0.04449 
OLR1553 1.077619 0.03914 
HRB2_PREDICTED 1.07758 0.025948 
MOCS1_PREDICTED 1.077005 0.009716 
LOC497720 1.076211 0.028002 
OLR1130 1.075598 0.020056 
KHSRP 1.074635 0.040214 
TNIP2 1.072005 0.005172 
LOC499255 1.071332 0.037413 
XPO5_PREDICTED 1.070685 0.038382 
LOC686701 1.069906 0.026783 
RGD1563824_PREDICTED 1.067894 0.031895 
SART1 1.066958 0.047447 
LOC502367 1.065927 0.038488 
INDO 1.065101 0.034784 
RGD1563599_PREDICTED 1.064128 0.028162 
RGD1564340_PREDICTED 1.060166 0.011641 
OLR450 1.059955 0.043339 
LOC678867 1.059637 0.035701 
RGD1564820_PREDICTED 1.059034 0.022257 
RGD1308133_PREDICTED 1.058645 0.023323 
MTA2 1.057806 0.024513 
RGD1563314_PREDICTED 1.057749 0.028096 
LOC367216 1.056833 0.031933 
PRKAA2 1.056365 0.039895 
RGD1560885_PREDICTED 1.056147 0.040058 
RGD1562963_PREDICTED 1.055917 0.033464 
OLR19 1.055749 0.03084 
RGD1310893_PREDICTED 1.055706 0.026203 
SLC1A4 1.055684 0.029326 
RSHL3_PREDICTED 1.05539 0.037019 
RGD1566018_PREDICTED 1.055116 0.040236 
IFIT2 1.054525 0.031285 
LOC502442 1.054159 0.02645 
RGD1565321_PREDICTED 1.053752 0.042136 
MYRIP 1.053671 0.036834 
TRPM1 1.053521 0.020178 
LOC500570 1.053231 0.021172 
LOC366089 1.052757 0.02794 
PBX2 1.052457 0.02067 
IGFBPL1_PREDICTED 1.052018 0.022924 
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GPHA2 1.051611 0.011901 
PARK2 1.051298 0.033253 
CALCB 1.051202 0.048596 
RGD1564563_PREDICTED 1.050908 0.017663 
LOC497854 1.050059 0.031617 
MLLT10 1.049515 0.033908 
OLR729 1.049308 0.045334 
LOC361113 1.049262 0.033175 
TOR3A 1.048827 0.041589 
RTTN_PREDICTED 1.048251 0.008869 
OLR1202 1.047239 0.02067 
SEPT6_PREDICTED 1.047011 0.015889 
LOC679745 1.046781 0.034113 
LOC360875 1.046718 0.04622 
LOC502010 1.046701 0.024621 
NRIP3_PREDICTED 1.046618 0.013824 
LOC363046 1.046178 0.009335 
OLR442 1.045878 0.032055 
RGD1563529_PREDICTED 1.045848 0.038149 
RGD1565760_PREDICTED 1.04584 0.042629 
LOC498933 1.045704 0.017211 
NEB_PREDICTED 1.045595 0.030722 
PDZD4_PREDICTED 1.045398 0.045326 
LOC499462 1.045029 0.036988 
MCPT1L4 1.04498 0.026542 
LECT2_PREDICTED 1.044941 0.022262 
LOC502455 1.044905 0.018427 
LOC497966 1.044533 0.028746 
RGD1311455_PREDICTED 1.044312 0.044057 
OLR397 1.044238 0.024471 
LIN7B 1.043026 0.017903 
LOC502769 1.042994 0.026273 
RGD1560010_PREDICTED 1.042654 0.031033 
RGD1560439_PREDICTED 1.042384 0.010456 
LOC685019 1.042258 0.024823 
LOC681591 1.042136 0.034383 
LOC497736 1.041666 0.029742 
LOC307706 1.041647 0.035051 
LOC503065 1.041645 0.00913 
CEACAM12_PREDICTED 1.04137 0.045639 
LOC363733 1.041121 0.029594 
MRGPRD 1.040906 0.047214 
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LOC497749 1.040602 0.02433 
LOC363221 1.040478 0.042276 
OLR990 1.039922 0.020374 
PTPN20_PREDICTED 1.039837 0.024095 
RGD1559890_PREDICTED 1.03907 0.025298 
CLCF1 1.038576 0.022182 
LOC502145 1.038333 0.030436 
LOC297380 1.038187 0.042542 
SLC32A1 1.037625 0.035073 
OLR1707 1.036929 0.026909 
CSRP3 1.036871 0.028606 
RGD1563232_PREDICTED 1.036846 0.04867 
LOC502168 1.036585 0.037467 
STK10 1.036503 0.020211 
LOC367613 1.036248 0.041 
MDH1B_PREDICTED 1.036213 0.035806 
SERPINB10 1.036124 0.032616 
LOC501226 1.035557 0.037859 
LOC502202 1.035136 0.041506 
GPX6 1.034538 0.037723 
OLR312 1.034493 0.038424 
OLR903 1.034184 0.029529 
RGD1564321_PREDICTED 1.033396 0.044848 
OLR1231 1.033299 0.029988 
ENTPD3 1.033285 0.039588 
LOC363214 1.033029 0.043821 
LOC685782 1.032636 0.042112 
OLR1196 1.031848 0.031684 
LOC502805 1.03177 0.042917 
HES3 1.03176 0.047956 
OLR1501 1.031561 0.029817 
LOC498742 1.031081 0.04591 
HS6ST3_PREDICTED 1.030615 0.036793 
LOC291561 1.03061 0.045769 
LOC501773 1.02894 0.044881 
OLR415 1.028704 0.037378 
V1RE17 0.9726948 0.041233 
LOC499445 0.9710425 0.039225 
NPY5R 0.970171 0.032765 
NEDD1_PREDICTED 0.9699001 0.037382 
LOC502551 0.9693686 0.045332 
LOC499700 0.968011 0.03208 
69	  
OLR245 0.9678475 0.023983 
LOC364917 0.9678257 0.027881 
LOC298627 0.9677331 0.029025 
AMELX 0.9673856 0.0407 
OLR537 0.9670878 0.037539 
LOC501362 0.9668261 0.039338 
LOC364004 0.9659279 0.045525 
RGD1310242 0.9657724 0.027384 
LOC501319 0.9657687 0.021049 
LOC499174 0.9656717 0.032318 
V1RF6 0.9652919 0.04514 
LOC289836 0.9648635 0.045097 
TMEM177 0.9646989 0.031111 
LOC315686 0.9644034 0.049968 
RGD1560626_PREDICTED 0.9643977 0.048912 
DMC1H_PREDICTED 0.9642695 0.030565 
NAB2 0.9629349 0.038593 
BMPR1B 0.9628443 0.02241 
OLR803 0.9627289 0.031046 
BPIL3_PREDICTED 0.9624104 0.030179 
RGD1560943_PREDICTED 0.9617314 0.023136 
LOC503068 0.9616882 0.035954 
OLR285 0.9615903 0.032811 
BRDT 0.9609238 0.041428 
LOC362682 0.9603859 0.030189 
GFOD1_PREDICTED 0.9600711 0.046398 
RAB3A 0.9600301 0.037624 
SRPX2_PREDICTED 0.9598493 0.03903 
LOC500535 0.9587579 0.047814 
LOC501057 0.9582686 0.04798 
LOC287211 0.9578096 0.033598 
LOC501828 0.9570083 0.017746 
RGD1561881_PREDICTED 0.9561352 0.015383 
NIPA1_PREDICTED 0.9558915 0.037238 
OLR850 0.9553405 0.033386 
OLR200 0.9550492 0.03349 
LOC499587 0.9547943 0.038914 
SAP18_PREDICTED 0.9547168 0.045078 
OLR206 0.9540717 0.03474 
LOC503275 0.9534122 0.019815 
LOC304484 0.9529269 0.049311 
RGD1307355 0.9527235 0.039664 
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LOC298795 0.9521916 0.038997 
LOC500460 0.9518366 0.038495 
SAA4 0.9516008 0.031657 
PRP-2 0.9513543 0.02266 
ZFPN1A5_PREDICTED 0.9506356 0.037233 
LOC499197 0.9503176 0.017826 
LOC365207 0.9497634 0.018665 
RGD1311358 0.9493432 0.007746 
RGD1560076_PREDICTED 0.9490962 0.017102 
LRRN6A 0.9490556 0.046011 
RGD1307621_PREDICTED 0.9489878 0.034045 
LOC306380 0.9487868 0.021621 
RGD1359634 0.9485024 0.015837 
OLR753 0.9483404 0.020071 
LOC500626 0.9476781 0.022795 
RGD1311447_PREDICTED 0.9474468 0.034991 
UBE4A 0.9467367 0.017853 
LOC363363 0.9466804 0.042418 
EZH1_PREDICTED 0.9462883 0.01658 
RGD1561467_PREDICTED 0.945913 0.028041 
LOC299759 0.9452384 0.009998 
LOC689246 0.9450563 0.046953 
LOC690081 0.9445552 0.02235 
RGD1305628_PREDICTED 0.9439074 0.041793 
DPDE1 0.9393354 0.022813 
CDC27 0.9354497 0.003211 
OLR1233 0.93504 0.041094 
RGD1563719_PREDICTED 0.9350293 0.025033 
PSMC6 0.9282862 0.044033 
GNB1 0.9281489 0.029943 
TERC 0.9280208 0.019751 
ZFP7_PREDICTED 0.9261646 0.005201 
NAPA 0.9252905 0.033035 
PTPRG 0.9243523 0.025269 
ANKS6 0.9196267 0.018583 
WDR45 0.913372 0.005602 
RGD1308872_PREDICTED 0.9070511 0.014454 
FEM1C_PREDICTED 0.906594 0.010759 
PPP2R5E_PREDICTED 0.9043209 0.015653 
TTC1 0.9004372 0.031565 
SUMO1 0.8984433 0.013549 
LOC499330 0.8958959 0.024111 
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CEPT1 0.8949682 0.015971 
MBIP_PREDICTED 0.8945419 0.026207 
SUI1-RS1_PREDICTED 0.8939435 0.042964 
RGD1308261_PREDICTED 0.8911549 0.010271 
MAK10 0.888854 0.044769 
FAM82A 0.873194 0.033748 
RGD1561287_PREDICTED 0.8730383 0.001179 
LOC499029 0.8696163 0.036196 
GSK3B 0.8676636 0.009406 
NFIB 0.858651 0.04736 
LOC497745 0.8460504 0.02781 
GBE1 0.8449171 0.039781 
NRIP1_PREDICTED 0.8445521 0.041392 
DIS3L 0.8371645 0.002566 
SKP1 0.8364486 0.043282 
HDAC5 0.8341304 0.027017 
TIPARP_PREDICTED 0.830436 0.017054 
CARHSP1 0.8288615 0.040445 
PTEN 0.8281376 0.032051 
DYNC1LI2 0.8238315 0.021849 
NQO2 0.8220294 0.035611 
LOC363306 0.813867 0.040276 
LOC502204 0.810841 0.01496 
DOCK6_PREDICTED 0.8060442 0.032398 
BCL2L13_PREDICTED 0.7988303 0.048243 
LOC306365 0.7796949 5.81E-05 
FRAG1 0.7637615 0.049072 
CLIC5 0.7566308 0.040523 
RGD1309676 0.7548345 0.0491 
NCOR1 0.7514342 0.004645 
MBC2 0.7300745 0.04275 
LOC500586 0.6917345 0.026157 
STAT6_PREDICTED 0.6881498 0.033623 
THRB 0.6500115 0.002953 
 
 
 
 
 
 
 
 
72	  
Table 8: Five Most Up- and Down-Regulated Genes between AMF Diet vs. Control Diet. 
AMF vs. Control 
 Gene ID 
Fold 
Change P-value 
Up-regulated 
1 THRB 1.648814 0.001891 
2 GADD45A 1.482974 0.028943 
3 TLE3 1.436228 0.017744 
4 ATP6V0E2 1.392623 0.02705 
5 MYD116 1.37152 0.040717 
Down-regulated 
1 LOC679886 0.5525963 0.032544 
2 ANP32A 0.6005893 0.024444 
3 PLCG2 0.6195253 0.04877 
4 RGD1565429_PREDICTED 0.6460851 0.040213 
5 RGD1565370_PREDICTED 0.6611232 0.019764 
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Table 9: Significantly Regulated Genes between AMF Diet vs. Control Diet in the 
Mucosa. 
 
 
AMF vs. Control 
Gene ID 
Fold 
change P-value 
THRB 1.648814 0.001891 
GADD45A 1.482974 0.028943 
TLE3 1.436228 0.017744 
ATP6V0E2 1.392623 0.02705 
MYD116 1.37152 0.040717 
PGD 1.369781 0.046088 
LOC497745 1.365174 0.005367 
MBOAT5 1.329787 0.039406 
GBE1 1.311789 0.011099 
VEGFA 1.305662 0.005513 
RGD1311249 1.265853 0.032513 
SNX24 1.260893 0.040967 
NQO2 1.240794 0.011496 
LOC290704 1.240503 0.040218 
DDX6 1.240355 0.04637 
LOC306365 1.213922 0.000463 
RALY 1.212045 0.044584 
LOC502204 1.209862 0.01948 
LOC297968 1.204828 0.020144 
LOC497735 1.201513 0.034662 
CLIC5 1.200085 0.008904 
NGRN 1.173344 0.016122 
RGD1560924_PREDICTED 1.171638 0.042585 
STAU1 1.17102 0.023977 
PI4KB 1.160573 0.028325 
RILP_PREDICTED 1.153948 0.039847 
MAPK7 1.152424 0.034954 
TNPO2_PREDICTED 1.149236 0.025595 
DDB1 1.141322 0.014044 
NDUFB7_PREDICTED 1.140521 0.036004 
RGD1565690_PREDICTED 1.137477 0.015414 
NAAA 1.133198 0.03955 
RGD1560991_PREDICTED 1.128196 0.026183 
LOC499029 1.12182 0.035432 
LOC361128 1.12103 0.025777 
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DOM3Z 1.117326 0.025928 
RGD1565095_PREDICTED 1.114568 0.026553 
BCL2L2 1.113572 0.040902 
RGD1311257 1.111859 0.007019 
RPS6KA5_PREDICTED 1.108046 0.021923 
LOC497959 1.106984 0.034711 
CDC42EP4_PREDICTED 1.105471 0.045929 
RGD1305013_PREDICTED 1.10454 0.03292 
COX6A1 1.101788 0.029051 
CDC27 1.099803 0.031872 
ARPC1A 1.096465 0.046443 
VAMP3 1.095696 0.009152 
ARMC8_PREDICTED 1.093959 0.006819 
LUC7L_PREDICTED 1.093647 0.018471 
TPM1 1.091879 0.027267 
SOS2 1.088683 0.018709 
BMP2K 1.078846 0.020277 
OPHN1_PREDICTED 1.074922 0.006977 
LOC296235 1.071353 0.013942 
USP38_PREDICTED 1.070679 0.040514 
RGD1305628_PREDICTED 1.068564 0.035121 
TERC 1.067618 0.041365 
GAPVD1_PREDICTED 1.067275 0.025101 
HRH3 1.067254 0.040894 
ZFPN1A5_PREDICTED 1.062026 0.01555 
RGD1562090_PREDICTED 1.054824 0.001346 
OLR544 1.054189 0.010025 
RGD1559747_PREDICTED 1.053949 0.02711 
LOC499040 1.052869 0.020326 
CPN1 1.05248 0.033524 
SEMA4C_PREDICTED 1.052316 0.012626 
THH_PREDICTED 1.051925 0.022798 
SMYD4_PREDICTED 1.051255 0.019326 
KIF2 1.050667 0.047367 
LOC501896 1.050345 0.035256 
EMR4 1.050189 0.020586 
RGD1560108_PREDICTED 1.049096 0.016298 
UGT2B5 1.048426 0.034199 
TTC14_PREDICTED 1.047715 0.020512 
LOC303019 1.04763 0.006062 
LOC306380 1.046956 0.049717 
MMP27_PREDICTED 1.046853 0.006213 
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DPDE1 1.046787 0.03372 
DOS_PREDICTED 1.04674 0.025513 
LOC299759 1.046372 0.027302 
LOC363662 1.045701 0.032254 
RGD1566120_PREDICTED 1.04462 0.037088 
RGD1561024_PREDICTED 1.043672 0.017634 
OLR481 1.043318 0.038949 
ENPP7 1.043316 0.041744 
LOC364517 1.042877 0.015985 
RGD1307418_PREDICTED 1.04221 0.044242 
LOC499590 1.042127 0.018975 
RGD1561161_PREDICTED 1.042055 0.024475 
OLR515 1.041755 0.039828 
FGF16 1.041085 0.048699 
LOC499065 1.040979 0.04395 
RGD1564463_PREDICTED 1.040404 0.02345 
LOC501057 1.040016 0.036183 
LOC498318 1.039995 0.040285 
NPY1R 1.039756 0.02827 
MRC2_PREDICTED 1.039353 0.008059 
RGD1311874_PREDICTED 1.039208 0.018783 
KCNV1 1.039154 0.047826 
OLR1156 1.038326 0.049391 
OLR1587 1.038046 0.032592 
NTRK2 1.038031 0.021878 
LOC288501 1.037826 0.0301 
LOC501173 1.037684 0.023992 
LOC361548 1.037679 0.034673 
FGL1 1.037335 0.024009 
LOC684990 1.036862 0.018634 
RGD1566037_PREDICTED 1.036808 0.021111 
KCNJ11 1.03676 0.016957 
MRGPRX1 1.036661 0.013962 
PRL3D4 1.03666 0.026492 
RGD1564091_PREDICTED 1.036642 0.042084 
RGD1562620_PREDICTED 1.03638 0.035923 
LOC367855 1.036304 0.038133 
KLRG1 1.035937 0.043335 
RHOX12 1.035769 0.02637 
LOC289701 1.034882 0.037174 
OLR582 1.034699 0.039815 
ASB7_PREDICTED 1.034636 0.041265 
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PDIA2_PREDICTED 1.034593 0.028229 
LOC498204 1.034577 0.027638 
TH 1.034518 0.04915 
EFHA2 1.034302 0.019063 
LOC499089 1.034167 0.039494 
OLR689 1.033852 0.037613 
PGLYRP1 1.033754 0.045246 
LOC503213 1.033592 0.041486 
LOC292455 1.033444 0.037034 
LOC690081 1.033165 0.039082 
LOC502768 1.033088 0.037208 
LOC497799 1.03304 0.033626 
LOC499643 1.032987 0.03467 
LOC501828 1.03288 0.039044 
RGD1560943_PREDICTED 1.032539 0.015453 
OLR1014 1.032521 0.030455 
OLR962 1.031765 0.023247 
LOC365608 1.031378 0.038367 
LOC365442 1.030022 0.048176 
LOC367484 1.029802 0.032419 
CEACAM9 1.029638 0.027512 
RGD1566325_PREDICTED 1.029498 0.040339 
LOC502534 1.029487 0.048885 
OLR371 1.029002 0.035658 
LOC367184 1.028616 0.045301 
LOC501596 1.027884 0.033752 
LOC499375 1.027223 0.049032 
LOC364787 1.026236 0.038033 
SLC7A3 1.026195 0.040097 
OLR880 1.02613 0.040798 
MBD3L1_PREDICTED 1.025452 0.032831 
RGD1564322_PREDICTED 0.9771035 0.04517 
OLR444 0.9758411 0.04439 
LOC689998 0.9746824 0.043538 
FAM131B 0.9742263 0.034762 
LOC502321 0.9741784 0.036458 
RGD1563314_PREDICTED 0.9741372 0.049264 
OLR802 0.9733601 0.048174 
RGD1559626_PREDICTED 0.9726902 0.035682 
PCCA 0.9719901 0.04478 
LOC498929 0.9716359 0.033014 
LOC303930 0.9707688 0.043912 
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LOC501408 0.9705877 0.048485 
SEC14L2 0.9703048 0.018369 
LOC299177 0.9699912 0.044483 
LOC312365 0.9699286 0.021085 
DMRT3_PREDICTED 0.9699218 0.04443 
LOC297380 0.9697848 0.044995 
LOC498336 0.9697323 0.032229 
LOC681273 0.9695807 0.033849 
OLR502 0.969448 0.042272 
LOC498055 0.9691922 0.038773 
LOC290876 0.9691643 0.023414 
RGD1565218_PREDICTED 0.9689119 0.047823 
RGD1559927_PREDICTED 0.9687044 0.027521 
LOC367793 0.9683847 0.044845 
MYBPC3_PREDICTED 0.9682997 0.025411 
RGD1561977_PREDICTED 0.9682531 0.037771 
RGD1359378 0.9681986 0.041449 
RGD1561827_PREDICTED 0.9679006 0.041643 
LOC499862 0.9678194 0.035186 
LOC364542 0.9676178 0.049603 
LOC366191 0.9675479 0.019152 
LOC367379 0.9675385 0.023441 
RGD1306636_PREDICTED 0.9674975 0.032119 
BAI3_PREDICTED 0.967411 0.043015 
RGD1560459_PREDICTED 0.9673474 0.041517 
RGD1564321_PREDICTED 0.9672595 0.049117 
LOC290339 0.9669739 0.019652 
OLR1766 0.9668288 0.04677 
LOC501074 0.9667374 0.017855 
LOC498554 0.9667062 0.026748 
GUK1_PREDICTED 0.9662925 0.04075 
LOC501437 0.966028 0.041108 
FASLG 0.9659854 0.031798 
LOC503416 0.9659326 0.026782 
OLR566 0.9657071 0.017156 
OLR1541 0.965695 0.040975 
RAI16_PREDICTED 0.9655608 0.04527 
LOC363901 0.9654598 0.035445 
LOC498535 0.9651541 0.028563 
RSHL3_PREDICTED 0.9651193 0.032086 
LOC497714 0.9650998 0.04659 
LOC298844 0.9649745 0.04169 
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LOC367613 0.9648586 0.037771 
LOC502442 0.9648101 0.041411 
RGD1559838_PREDICTED 0.9647695 0.033289 
LOC363411 0.9647381 0.035605 
KRT76 0.9646761 0.022283 
LOC500480 0.9645442 0.012695 
RGD1564998_PREDICTED 0.9644918 0.041084 
RGD1307128 0.9641893 0.026454 
LOC501824 0.9641621 0.017295 
RGD1560775_PREDICTED 0.9636256 0.02995 
TMPRSS11E_PREDICTED 0.96358 0.008543 
RGD1564278_PREDICTED 0.9634784 0.049478 
SERPINF2_PREDICTED 0.9632917 0.044529 
LOC689577 0.9626366 0.045182 
MGC114246 0.9626266 0.049525 
CLDN16 0.9625545 0.033231 
LIN7B 0.9624435 0.023848 
LOC295487 0.9623293 0.040741 
ZFP819 0.9622048 0.027382 
RGD1562281_PREDICTED 0.9621804 0.010188 
MDC1 0.962171 0.023073 
FANCC 0.9621238 0.027453 
LOC501617 0.9618896 0.03195 
OLR1196 0.9616962 0.015633 
ATP6V1B1_PREDICTED 0.9613485 0.026649 
NR0B1 0.9613276 0.012178 
LOC367239 0.9613189 0.045135 
LOC501581 0.9611504 0.023798 
LOC498766 0.9610334 0.017979 
LY6G6F 0.9609991 0.028439 
CWF19L2_PREDICTED 0.960991 0.021622 
LOC365807 0.9609174 0.04283 
ABCC4 0.9608613 0.036135 
RAMP3 0.9608077 0.040252 
CCR8_PREDICTED 0.9605914 0.02789 
RGD1305844 0.9605882 0.041272 
V1RD26 0.9605712 0.045874 
LOC503135 0.9603225 0.042919 
RGD1564536_PREDICTED 0.9603074 0.01943 
UGT2A3_PREDICTED 0.9602854 0.023055 
SEZ6L2_PREDICTED 0.9598799 0.04747 
LOC498646 0.9597731 0.010141 
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OLR1707 0.9595897 0.013261 
LOC502741 0.9594814 0.026683 
LOC497709 0.9593818 0.035634 
LOC687718 0.9591694 0.023764 
OLR674 0.9590577 0.012388 
BAI2_PREDICTED 0.9589612 0.01309 
SUSD2_PREDICTED 0.958896 0.043888 
RGD1559605_PREDICTED 0.9588738 0.043964 
RGD1561474_PREDICTED 0.9587686 0.028842 
OLR1490 0.9587338 0.008583 
LOC503299 0.9586632 0.006649 
MGAT5B_PREDICTED 0.9585639 0.012567 
OLR776 0.9585 0.024511 
LOC365973 0.9584243 0.014551 
AKP5_PREDICTED 0.9583529 0.027597 
RGD1560010_PREDICTED 0.9583051 0.032162 
CLDN1 0.9581912 0.039826 
ELF5_PREDICTED 0.9578875 0.008521 
PBX2 0.9577232 0.005031 
LOC679081 0.9575288 0.008388 
LOC361113 0.9574016 0.022994 
NOS1AP 0.957136 0.031819 
RGD1565951_PREDICTED 0.9570382 0.011033 
RGD1307503_PREDICTED 0.956965 0.026578 
OLR1607 0.9569403 0.02583 
LOC307056 0.9567329 0.04753 
RGD1562409_PREDICTED 0.9566516 0.005889 
RGD1561747_PREDICTED 0.9564278 0.023259 
LOC502096 0.9563482 0.009291 
LOC297908 0.9561734 0.039484 
RGD1563468_PREDICTED 0.9559377 0.029261 
CML1 0.9559085 0.039851 
RGD1565815_PREDICTED 0.9557428 0.012551 
ALX1 0.9557012 0.020252 
LOC363408 0.9555861 0.011835 
RGD1562936_PREDICTED 0.9553678 0.04226 
LOC682990 0.955314 0.043684 
FCHSD1_PREDICTED 0.9553062 0.007462 
LOC503267 0.9549733 0.005904 
LOC503279 0.9547627 0.031716 
OLR165 0.9547071 0.047379 
RGD1565341_PREDICTED 0.9546177 0.009555 
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PDYN 0.9544685 0.009689 
ZFP509_PREDICTED 0.9539331 0.008369 
RGD1560559_PREDICTED 0.9535066 0.039348 
PIGK_PREDICTED 0.9533864 0.016677 
LOC502251 0.9532149 0.028205 
VSIG4 0.9531481 0.030408 
LOC497892 0.9528155 0.039816 
IGFBPL1_PREDICTED 0.9522782 0.027661 
RGD1560359_PREDICTED 0.9521496 0.006165 
LOC502717 0.9521175 0.009377 
MYH6 0.9519573 0.03133 
NEB_PREDICTED 0.9515993 0.002641 
RGD1563529_PREDICTED 0.9515452 0.029839 
ZBTB40_PREDICTED 0.9513442 0.027978 
MYRIP 0.9512404 0.029197 
LOC501443 0.950496 0.047977 
SLC4A1 0.9492819 0.035733 
RGD1309368_PREDICTED 0.9490792 0.021081 
OLR867 0.9478762 0.033114 
RGD1559936_PREDICTED 0.9471805 0.023087 
LOC688887 0.9468382 0.031763 
LOC500241 0.9466898 0.027648 
OLR1130 0.9461882 0.020596 
LOC310177 0.945955 0.03115 
RGD1304810_PREDICTED 0.9458428 0.047524 
OLR1616 0.9453517 0.03591 
OTUD4 0.9450602 0.027237 
KLRH1 0.9448113 0.017055 
RGD1561297_PREDICTED 0.9433139 0.00529 
OLR860 0.9431456 0.003429 
DDX27_PREDICTED 0.942116 0.030531 
RGD1307749_PREDICTED 0.9415713 0.044369 
LOC687381 0.9411153 0.007208 
GMCL1 0.9409451 0.009577 
MDH1B_PREDICTED 0.940359 0.039063 
RPE65 0.9399174 0.00791 
RGD1565301_PREDICTED 0.9396695 0.010223 
LOC502605 0.9396578 0.047393 
PAIP2_PREDICTED 0.9392289 0.006717 
CDCP1_PREDICTED 0.9388176 0.048615 
DDX26_PREDICTED 0.9380783 0.010483 
CAMK2D 0.9379321 0.020169 
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TARBP2 0.9377559 0.049122 
PPM1D_PREDICTED 0.936378 0.006202 
ZW10_PREDICTED 0.9352452 0.016125 
LOC498354 0.9334159 0.006841 
PLA2G4B_PREDICTED 0.9324469 0.04466 
NEU3 0.9323969 0.04893 
RGD1561833_PREDICTED 0.9323569 0.005613 
NRP2 0.9323062 0.035176 
RCE1 0.9321974 0.045467 
KCNJ5 0.9309085 0.033311 
EPM2AIP1_PREDICTED 0.9272652 0.006461 
LOC501328 0.9270424 0.015979 
LOC316373 0.9258927 0.017265 
COLEC10_PREDICTED 0.9247391 0.000877 
TRDMT1 0.9233845 0.011952 
ATP2B3 0.9226804 0.038814 
LOC309854 0.922236 0.005526 
BPGM 0.9198521 0.007336 
PI4KA 0.9195563 0.013635 
LOC361485 0.9183124 0.025038 
RGD1563503_PREDICTED 0.9180285 0.015186 
PSIP1 0.9179075 0.015923 
MCOLN3 0.9178202 0.01869 
DHX29_PREDICTED 0.9166912 0.012592 
CBFA2T3_PREDICTED 0.9163268 0.042625 
LOC363018 0.9139024 0.013848 
BIRC2 0.9114053 0.043963 
ARV1_PREDICTED 0.9087453 0.004977 
ZFP414 0.9059381 0.003805 
TDRD3 0.9053056 0.025633 
RGD1561676_PREDICTED 0.9049927 0.028034 
LOC257650 0.904629 0.002053 
UBLCP1 0.9004358 0.039885 
SFMBT1 0.8999878 0.021516 
RGD1563508_PREDICTED 0.8997248 0.003674 
DHX9_PREDICTED 0.8990104 0.00835 
TREX1 0.8983206 0.041483 
TIA1_PREDICTED 0.8964272 0.018346 
FOXO1A 0.8923143 0.025052 
ITGB1BP2_PREDICTED 0.8884494 0.039183 
LOC501387 0.8883633 0.047099 
SMC6L1_PREDICTED 0.8872671 0.037079 
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BRD8 0.8871332 0.046725 
CRNKL1 0.8843491 0.004306 
AGMAT 0.8833762 0.033046 
PLA2G4A 0.8818804 0.012253 
CPEB2_PREDICTED 0.8813915 0.005638 
LOC300760 0.8813727 0.008994 
RGD1563824_PREDICTED 0.881063 0.01099 
EIF1AD 0.878956 0.021435 
LOC500054 0.878036 0.022023 
RGD1562469_PREDICTED 0.8758118 0.038167 
RGD1564130_PREDICTED 0.8749405 0.047331 
ZMYM1_PREDICTED 0.8733207 0.048932 
CLNS1A 0.8723373 0.002755 
RBM16 0.871915 0.010335 
PAPD5_PREDICTED 0.8701424 0.00839 
RALGDS 0.8692854 0.020637 
RGD1563739_PREDICTED 0.8681307 0.048434 
MYST2 0.868076 0.022747 
EPC1_PREDICTED 0.8670012 0.011706 
PCF11_PREDICTED 0.8666774 0.003202 
RGD1559149_PREDICTED 0.8659628 0.025533 
RGD1311091_PREDICTED 0.8646252 0.035693 
LOC292069 0.861492 0.04615 
LOC498078 0.859849 0.027305 
TRIM39 0.8581252 0.001657 
RGD1561587_PREDICTED 0.8568872 0.042104 
THRAP3 0.8560886 0.036508 
DDX20 0.8544825 0.005625 
RGD1564914_PREDICTED 0.8544731 0.015197 
LOC498824 0.8541985 0.03909 
LOC497663 0.8535118 0.042652 
ZFP472 0.8533822 0.042692 
ZSWIM3_PREDICTED 0.8529162 0.00729 
RGD1559461_PREDICTED 0.8520888 0.024782 
RGD1561198_PREDICTED 0.8515368 0.035041 
SDAD1 0.850369 0.027994 
RGD1565385_PREDICTED 0.8498643 0.017426 
DHPS 0.8489293 0.012041 
RGD1564051_PREDICTED 0.8486854 0.016749 
PHTF1 0.8468986 0.004338 
CTCF 0.8451852 0.046414 
RGD1564055_PREDICTED 0.8414673 0.002481 
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RPL3 0.8391267 0.019274 
AKAP8 0.8366854 0.025911 
LOC360910 0.8295648 0.016985 
LOC309478 0.8267659 0.015024 
LOC306137 0.8262987 0.020773 
RGD1561135_PREDICTED 0.8214955 0.011584 
RPL24 0.8191009 0.039127 
LOC308503 0.8106066 0.04013 
LOC361269 0.8084798 0.01938 
RGD1560903_PREDICTED 0.8058301 0.030693 
IK 0.8046826 0.01694 
RGD1565767_PREDICTED 0.8035404 0.013441 
PCP4 0.7980791 0.040319 
CD2BP2_PREDICTED 0.7977781 0.029779 
RGD1565306_PREDICTED 0.7946483 0.015997 
LOC498750 0.7903675 0.008309 
NSUN2_PREDICTED 0.7888668 0.049597 
LOC294781 0.7841423 0.022225 
RGD1563311_PREDICTED 0.783321 0.025418 
LOC365059 0.7827806 0.017552 
DUSP6 0.7590765 0.034579 
OPLAH 0.7570179 0.047427 
RGD1560186_PREDICTED 0.7519166 0.04758 
RGD1562835_PREDICTED 0.7445235 0.018501 
RGD1562404_PREDICTED 0.7428536 0.011787 
RGD1565117_PREDICTED 0.7425289 0.018967 
RGD1560979_PREDICTED 0.7264331 0.037889 
LOC300731 0.7214959 0.013613 
LOC298495 0.70271 0.022878 
PSMB9 0.6935654 0.007546 
RGD1563431_PREDICTED 0.6864675 0.049562 
LOC684988 0.6611639 0.007198 
RGD1565370_PREDICTED 0.6611232 0.019764 
RGD1565429_PREDICTED 0.6460851 0.040213 
PLCG2 0.6195253 0.04877 
ANP32A 0.6005893 0.024444 
LOC679886 0.5525963 0.032544 
 
 
 
84	  
 
 
 
 
 
 
 
 
 
 
 
APPENDIX B. PERMISSIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
85	  
March 25, 2010 
 
Dallin R. Snow 
750 N 1200 E 
Logan, Utah 84322-8700 
435-797-2313 | dallin.snow@aggiemail.usu.edu 
Fax: 435-797-2379	  
 
Journal of Agricultural and Food Chemistry 
 
To Permissions Editor: 
 
I am preparing my thesis in the Nutrition, Dietetics and Food Sciences Department at 
Utah State University. I hope to complete my degree in the spring of 2010. 
 
An article, “Dietary Milk Fat Globule Membrane Reduces the Incidence of Aberrant 
Crypt Foci in Fischer-344 Rats”, of which I am first author, and which appeared in your 
journal (2010 Feb 24, 58 (4), pp 2157-2163), reports an essential part of my thesis 
research. I would like permission to reprint it as a chapter in my thesis. (Reprinting the 
chapter may necessitate some revision.) Please note that USU sends theses to Bell & 
Howell Dissertation Services to be made available for reproduction. 
 
I will include an acknowledgment to the article on the first page of the chapter, as shown 
below. Copyright and permission information will be included in a special appendix. If 
you would like a different acknowledgment, please so indicate. 
 
Please indicate your approval of this request by signing in the space provided, and attach 
any other form necessary to confirm permission. If you charge a reprint fee for use of an 
article by the author, please indicate that as well. 
 
If you have any questions, please call me at the number above or send me an e-mail 
message at the above address. Thank you for your assistance. 
 
Sincerely, 
 
Dallin Snow 
 
I hereby give permission to Dallin Snow to reprint the requested article in his thesis, with 
the following acknowledgment: 
 
Reproduced with permission from Snow, D. R.; Jimenez-Flores, R.; Ward, R. E.; 
Cambell, J.; Young, M. J.; Nemere, I.; Hintze, K. J. Dietary milk fat globule membrane 
reduces the incidence of aberrant crypt foci in fischer-344 rats. J. Agric. Food Chem. 
2010, 58 (4), 2157-2163. Copyright 2010 American Chemical Society. 
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American Chemical Society’s Policy on Theses and Dissertations 
If your university requires a signed copy of this letter see contact information below. 
Thank you for your request for permission to include your paper(s) or portions of text 
from your paper(s) in your thesis. Permission is now automatically granted; please pay 
special attention to the implications paragraph below. The Copyright Subcommittee of 
the Joint Board/Council Committees on Publications approved the following:  
 
Copyright permission for published and submitted material from theses and 
dissertations. 
ACS extends blanket permission to students to include in their theses and 
dissertations their own articles, or portions thereof, that have been published in 
ACS journals or submitted to ACS journals for publication, provided that the 
ACS copyright credit line is noted on the appropriate page(s).  
 
Publishing implications of electronic publication of theses and dissertation 
material. 
Students and their mentors should be aware that posting of theses and dissertation 
material on the Web prior to submission of material from that thesis or 
dissertation to an ACS journal may affect publication in that journal. Whether 
Web posting is considered prior publication may be evaluated on a case-by-case 
basis by the journal’s editor. If an ACS journal editor considers Web posting to be 
“prior publication”, the paper will not be accepted for publication in that journal. 
If you intend to submit your unpublished paper to ACS for publication, check 
with the appropriate editor prior to posting your manuscript electronically.  
 
If your paper has not yet been published by ACS, we have no objection to your including 
the text or portions of the text in your thesis/dissertation in print and microfilm 
formats; please note, however, that electronic distribution or Web posting of the 
unpublished paper as part of your thesis in electronic formats might jeopardize 
publication of your paper by ACS. Please print the following credit line on the first page 
of your article: "Reproduced (or 'Reproduced in part') with permission from [JOURNAL 
NAME], in press (or 'submitted for publication'). Unpublished work copyright 
[CURRENT YEAR] American Chemical Society." Include appropriate information.  
 
If your paper has already been published by ACS and you want to include the text or 
portions of the text in your thesis/dissertation in print or microfilm formats, please print 
the ACS copyright credit line on the first page of your article: “Reproduced (or 
'Reproduced in part') with permission from [FULL REFERENCE CITATION.] 
Copyright [YEAR] American Chemical Society." Include appropriate information.  
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Submission to a Dissertation Distributor: If you plan to submit your thesis to UMI or 
to another dissertation distributor, you should not include the unpublished ACS paper in 
your thesis if the thesis will be disseminated electronically, until ACS has published your 
paper. After publication of the paper by ACS, you may release the entire thesis (not the 
individual ACS article by itself) for electronic dissemination through the distributor; 
ACS’s copyright credit line should be printed on the first page of the ACS paper.  
 
Use on an Intranet: The inclusion of your ACS unpublished or published manuscript is 
permitted in your thesis in print and microfilm formats. If ACS has published your paper 
you may include the manuscript in your thesis on an intranet that is not publicly 
available. Your ACS article cannot be posted electronically on a publicly available 
medium (i.e. one that is not password protected), such as but not limited to, electronic 
archives, Internet, library server, etc. The only material from your paper that can be 
posted on a public electronic medium is the article abstract, figures, and tables, and you 
may link to the article’s DOI or post the article’s author-directed URL link provided by 
ACS. This paragraph does not pertain to the dissertation distributor paragraph above.  
 
Questions? Call +1 202/872-4368/4367. Send e-mail to copyright@acs.org or fax to +1 
202-776-8112.  
10/10/03, 01/15/04, 06/07/06  
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From: Copyright <Copyright@acs.org> 
To: Dallin Snow <dallin.snow@aggiemail.usu.edu> 
Date: Fri, Mar 26, 2010 at 7:46 AM 
Subject: RE: My University Requires signed copy for Thesis 
 
Dear Dallin Snow, 
This is in reference to your message below and to your attachment. 
In case you did not receive our out-of-office message when you sent us your request, our 
office is no longer accepting permission requests or forms (either by email, fax, or mail) 
for ACS journal material.  
We no longer send letters to students who want to use ACS journal articles in their 
theses/dissertations; therefore, you should notify your University so they no longer tell 
students to obtain a signed letters (most publishers are now using the Rightslink 
permission system so that requesters can obtain permission).  ACS requires all requesters 
to use the Rightslink permission system to obtain permission to use the ACS journal 
material.  
C. Arleen Courtney 
Copyright Associate 
Copyright, Permissions, & Licensing  
Office of Secretary & General Counsel 
American Chemical Society 
1155 Sixteenth Street, NW 
Washington, DC  20036 
Email. a_courtney@acs.org / Dept. Email. copyright@acs.org 
Tel. 202-872-4368 / Fax. 202-776-8112 
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March 26, 2010 
 
Dallin R. Snow 
750 N 1200 E 
Logan, Utah 84322-8700 
435-797-2313	  
 
Dear Michael J. Young: 
 
I am in the process of preparing my thesis in the Department of Nutrition, Dietetics and 
Food Sciences at Utah State University. I hope to complete my degree in the spring of 
2010.  
 
I am requesting your permission to include the attached material as shown. I will include 
acknowledgments and/or appropriate citations to your work as shown and copyright and 
reprint rights information in a special appendix. The bibliographical citation will appear 
at the end of the manuscript as shown. Please advise me of any changes you require. 
 
Please indicate your approval of this request by signing in the space provided, attaching 
any other form or instruction necessary to confirm permission.  
 
If you charge a reprint fee for use of your material, please indicate that as well. If you 
have any questions, please call me at the number above. 
 
I hope you will be able to reply immediately. If you are not the copyright holder, please 
forward my request to the appropriate person or institution. 
 
Thank you for your cooperation, 
 
Dallin Snow 
 
 
March 29, 2010 
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Dallin R. Snow 
750 N 1200 E 
Logan, Utah 84322-8700 
435-797-2313	  
 
Dear Rafael Jimenez-Flores: 
 
I am in the process of preparing my thesis in the Department of Nutrition, Dietetics and 
Food Sciences at Utah State University. I hope to complete my degree in the spring of 
2010.  
 
I am requesting your permission to include the attached material as shown. I will include 
acknowledgments and/or appropriate citations to your work as shown and copyright and 
reprint rights information in a special appendix. The bibliographical citation will appear 
at the end of the manuscript as shown. Please advise me of any changes you require. 
 
Please indicate your approval of this request by signing in the space provided, attaching 
any other form or instruction necessary to confirm permission.  
 
If you charge a reprint fee for use of your material, please indicate that as well. If you 
have any questions, please call me at the number above. 
 
I hope you will be able to reply immediately. If you are not the copyright holder, please 
forward my request to the appropriate person or institution. 
 
Thank you for your cooperation, 
 
Dallin Snow 
  
 
March 29, 2010 
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Dallin R. Snow 
750 N 1200 E 
Logan, Utah 84322-8700 
435-797-2313	  
 
Dear Jesse Campbell: 
 
I am in the process of preparing my thesis in the Department of Nutrition, Dietetics and 
Food Sciences at Utah State University. I hope to complete my degree in the spring of 
2010.  
 
I am requesting your permission to include the attached material as shown. I will include 
acknowledgments and/or appropriate citations to your work as shown and copyright and 
reprint rights information in a special appendix. The bibliographical citation will appear 
at the end of the manuscript as shown. Please advise me of any changes you require. 
 
Please indicate your approval of this request by signing in the space provided, attaching 
any other form or instruction necessary to confirm permission.  
 
If you charge a reprint fee for use of your material, please indicate that as well. If you 
have any questions, please call me at the number above. 
 
I hope you will be able to reply immediately. If you are not the copyright holder, please 
forward my request to the appropriate person or institution. 
 
Thank you for your cooperation, 
 
Dallin Snow 
 
